Bristol-Myers Squibb Company
Industry and Market Reports

 

List of associated reports

Below is a list of reports where Bristol-Myers Squibb Company is mentioned. The list of reports for the company is categorised by Industry, Region and report type. This categorisation along with the number of reports in each category is shown in the region on the left.

Many of the reports mention companies other than Bristol-Myers Squibb Company in the same report. This provides an indication of potential competitors or associated to Bristol-Myers Squibb Company. The relevance ranking is a measure of how many times both companies are mentioned in the same reported. These associated companies can me clicked to find out more about the company.

View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer (NSCLC) - Current and Future Players

Non-Small Cell Lung Cancer (NSCLC) - Current and Future Players


2016-11-03
GlobalData has released its pharma report, “Non-Small Cell Lung Cancer (NSCLC) - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing NSCLC Market....
  • Market Report
  • Oncology
  • Global
  • $2,995.00
  • Report 05IC-GDHC1066FPR has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC1066FPR
  • View Report: Research and Experts Market Report: Vitiligo Global Clinical Trials Review, H2, 2016

    Vitiligo Global Clinical Trials Review, H2, 2016


    2016-12-14
    GlobalData's clinical trial report, “Vitiligo Global Clinical Trials Review, H2, 2016" provides an overview of Vitiligo clinical trials scenario. This report provides top line data relating to the clinical trials on Vitiligo. Report includes...
  • Market Report
  • Dermatology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3999CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3999CTIDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016

    Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Glioblastoma Multiforme (GBM) – Pipeline Review, H2 2016, provides an overview of the Glioblastoma Multiforme (GBM) (Oncology) pipeline landscape.

    Glioblastoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8858IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8858IDB
  • View Report: Research and Experts Market Report: Progressive Supranuclear Palsy - Pipeline Review, H2 2016

    Progressive Supranuclear Palsy - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Progressive Supranuclear Palsy – Pipeline Review, H2 2016, provides an overview of the Progressive Supranuclear Palsy (Central Nervous System) pipeline landscape.

    Pr...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8855IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8855IDB
  • View Report: Research and Experts Market Report: Liver Cancer - Pipeline Review, H2 2016

    Liver Cancer - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Cancer – Pipeline Review, H2 2016, provides an overview of the Liver Cancer (Oncology) pipeline landscape.

    Liver cancer starts in the liver. The risk...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8854IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8854IDB
  • View Report: Research and Experts Market Report: Liver Fibrosis Global Clinical Trials Review, H2, 2016

    Liver Fibrosis Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Liver Fibrosis Global Clinical Trials Review, H2, 2016" provides an overview of Liver Fibrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Liver Fibrosis....
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3938CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3938CTIDB
  • View Report: Research and Experts Market Report: Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H2, 2016

    Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H2, 2016" provides an overview of Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) clinical trials scenario....
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3920CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3920CTIDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H2 2016

    Colorectal Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer – Pipeline Review, H2 2016, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape.

    Colon cancer is cancer that starts...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8870IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8870IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Myelocytic Leukemia – Pipeline Review, H2 2016, provides an overview of the Acute Myelocytic Leukemia (Oncology) pipeline landscape.

    Acute myelocytic...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8869IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8869IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H2 2016

    Melanoma - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Melanoma – Pipeline Review, H2 2016, provides an overview of the Melanoma (Oncology) pipeline landscape.

    Melanoma is a tumor that develops as a result of the...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8868IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8868IDB
  • View Report: Research and Experts Market Report: Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2016

    Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Human Immunodeficiency Virus Infections (AIDS) – Pipeline Review, H2 2016, provides an overview of the Human Immunodeficiency Virus Infections (AIDS) (Infectious...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8867IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8867IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H2 2016

    Ovarian Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer – Pipeline Review, H2 2016, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape.

    Ovarian cancer is any cancerous growth...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8866IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8866IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H2 2016

    Rheumatoid Arthritis - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis – Pipeline Review, H2 2016, provides an overview of the Rheumatoid Arthritis (Immunology) pipeline landscape.

    Rheumatoid arthritis (RA)...

  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8865IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8865IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H2 2016

    Non-Small Cell Lung Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Small Cell Lung Cancer – Pipeline Review, H2 2016, provides an overview of the Non-Small Cell Lung Cancer (Oncology) pipeline landscape.

    Non-small cell...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8864IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8864IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H2 2016

    Pancreatic Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer – Pipeline Review, H2 2016, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape.

    Pancreatic cancer is a disease in...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8862IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8862IDB
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H2 2016

    Neuropathic Pain - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain – Pipeline Review, H2 2016, provides an overview of the Neuropathic Pain (Central Nervous System) pipeline landscape.

    Neuropathic pain, or...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8861IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8861IDB
  • View Report: Research and Experts Market Report: Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or...

    Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct’s, ‘Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) - Pipeline Review, H2 2016’,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0683TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0683TDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H2 2016

    Prostate Cancer - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Prostate Cancer (Oncology) pipeline landscape.

    Prostate cancer is a form of cancer that...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8860IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8860IDB
  • View Report: Research and Experts Market Report: Multiple Sclerosis - Pipeline Review, H2 2016

    Multiple Sclerosis - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Sclerosis – Pipeline Review, H2 2016, provides an overview of the Multiple Sclerosis (Central Nervous System) pipeline landscape.

    Multiple sclerosis...

  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8845IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8845IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2016

    Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Myeloma (Kahler Disease) – Pipeline Review, H2 2016, provides an overview of the Multiple Myeloma (Kahler Disease) (Oncology) pipeline landscape.

    Multiple...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8844IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8844IDB
  • View Report: Research and Experts Market Report: Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Pipeline Review, H2 2016

    Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Granulomatosis with Polyangiitis (Wegener Polyangiitis) – Pipeline Review, H2 2016, provides an overview of the Granulomatosis with Polyangiitis (Wegener Polyangiitis...
  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8834IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8834IDB
  • View Report: Research and Experts Market Report: Sicca Syndrome (Sjogren) - Pipeline Review, H2 2016

    Sicca Syndrome (Sjogren) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sicca Syndrome (Sjogren) – Pipeline Review, H2 2016, provides an overview of the Sicca Syndrome (Sjogren) (Immunology) pipeline landscape.

    Sjogren's syndrome...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8821IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8821IDB
  • View Report: Research and Experts Market Report: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016

    Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer (Renal Cell Cancer) – Pipeline Review, H2 2016, provides an overview of the Kidney Cancer (Renal Cell Cancer) (Oncology) pipeline landscape.

    Kidney...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8816IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8816IDB
  • View Report: Research and Experts Market Report: Progressive Supranuclear Palsy Global Clinical Trials Review, H2, 2016

    Progressive Supranuclear Palsy Global Clinical Trials Review, H2, 2016


    2016-11-22
    GlobalData's clinical trial report, “Progressive Supranuclear Palsy Global Clinical Trials Review, H2, 2016" provides an overview of Progressive Supranuclear Palsy clinical trials scenario. This report provides top line data relating to...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3918CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3918CTIDB
  • View Report: Research and Experts Market Report: Thromboembolism Global Clinical Trials Review, H2, 2016

    Thromboembolism Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Thromboembolism Global Clinical Trials Review, H2, 2016" provides an overview of Thromboembolism clinical trials scenario. This report provides top line data relating to the clinical trials on Thromboembolism...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3887CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3887CTIDB
  • View Report: Research and Experts Market Report: Venous Thromboembolism Global Clinical Trials Review, H2, 2016

    Venous Thromboembolism Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H2, 2016" provides an overview of Venous Thromboembolism clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3886CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3886CTIDB
  • View Report: Research and Experts Market Report: Atrial Flutter Global Clinical Trials Review, H2, 2016

    Atrial Flutter Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Atrial Flutter Global Clinical Trials Review, H2, 2016" provides an overview of Atrial Flutter clinical trials scenario. This report provides top line data relating to the clinical trials on Atrial Flutter....
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3883CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3883CTIDB
  • View Report: Research and Experts Market Report: Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H2, 2016

    Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H2, 2016" provides an overview of Muscle Invasive Bladder Cancer (MIBC) clinical trials scenario. This report provides top line data...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3881CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3881CTIDB
  • View Report: Research and Experts Market Report: Salivary Gland Cancer Global Clinical Trials Review, H2, 2016

    Salivary Gland Cancer Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Salivary Gland Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Salivary Gland Cancer clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3878CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3878CTIDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0670TDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC0670TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0669TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0669TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene...

    Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H2 2016’,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0657TDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC0657TDB
  • View Report: Research and Experts Market Report: Neuroendocrine Tumors - Pipeline Review, H2 2016

    Neuroendocrine Tumors - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroendocrine Tumors – Pipeline Review, H2 2016, provides an overview of the Neuroendocrine Tumors (Oncology) pipeline landscape.

    Neuroendocrine tumor begins...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8809IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8809IDB
  • View Report: Research and Experts Market Report: Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2016

    Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bile Duct Cancer (Cholangiocarcinoma) – Pipeline Review, H2 2016, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma) (Oncology) pipeline landscape.

    Bi...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8808IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8808IDB
  • View Report: Research and Experts Market Report: E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protein...

    E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protein 3 or X Linked Inhibitor Of Apoptosis Protein or XIAP or EC 6.3.2.) - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct’s, ‘E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protein 3 or X Linked Inhibitor Of Apoptosis Protein or XIAP or EC 6.3.2.) - Pipeline Review,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0650TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0650TDB
  • View Report: Research and Experts Market Report: Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) - Pipeline Review, H2 2016

    Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct’s, ‘Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) - Pipeline Review, H2 2016’, provides in depth analysis on Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) targeted pipeline therapeutics....
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0645TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0645TDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H2 2016

    Metastatic Breast Cancer - Pipeline Review, H2 2016


    2016-12-07
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Breast Cancer - Pipeline Review, H2 2016, provides an overview of the Metastatic Breast Cancer (Oncology) pipeline landscape.

    Metastatic breast cancer...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8794IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8794IDB
  • View Report: Research and Experts Market Report: Hypereosinophilic Syndrome - Pipeline Review, H2 2016

    Hypereosinophilic Syndrome - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypereosinophilic Syndrome - Pipeline Review, H2 2016, provides an overview of the Hypereosinophilic Syndrome (Hematological Disorders) pipeline landscape.

    The hyper...

  • Market Report
  • Hematological Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8760IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8760IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Pipeline Review, H2 2016, provides an overview of the Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

    Non-Hodgkin lymphoma (also known...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8759IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8759IDB
  • View Report: Research and Experts Market Report: End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H2 2016

    End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide End-Stage Kidney Disease - Pipeline Review, H2 2016, provides an overview of the End-Stage Kidney Disease (Genito Urinary System And Sex Hormones) pipeline landscape....
  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8754IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8754IDB
  • View Report: Research and Experts Market Report: Nephrotic Syndrome - Pipeline Review, H2 2016

    Nephrotic Syndrome - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nephrotic Syndrome - Pipeline Review, H2 2016, provides an overview of the Nephrotic Syndrome (Genito Urinary System And Sex Hormones) pipeline landscape.

    Nephrotic...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8753IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8753IDB
  • View Report: Research and Experts Market Report: Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Pipeline Review, H2 2016

    Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Pipeline Review, H2 2016, provides an overview of the Vaso-Occlusive Crisis Associated With Sickle Cell...
  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8750IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8750IDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma - Pipeline Review, H2 2016

    Hepatocellular Carcinoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatocellular Carcinoma - Pipeline Review, H2 2016, provides an overview of the Hepatocellular Carcinoma (Oncology) pipeline landscape.

    Hepatocellular carcinoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8748IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8748IDB
  • View Report: Research and Experts Market Report: Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H2, 2016

    Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Extrahepatic Bile Duct Cancer clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3873CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3873CTIDB
  • View Report: Research and Experts Market Report: Pediatric Cancer Global Clinical Trials Review, H2, 2016

    Pediatric Cancer Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Pediatric Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Pediatric Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Pediatric...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3867CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3867CTIDB
  • View Report: Research and Experts Market Report: Intestinal Cancer Global Clinical Trials Review, H2, 2016

    Intestinal Cancer Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Intestinal Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Intestinal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Intestinal...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3866CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3866CTIDB
  • View Report: Research and Experts Market Report: Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016

    Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Follicular Thyroid Cancer clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3865CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3865CTIDB
  • View Report: Research and Experts Market Report: Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) - Pipeline Review, H2 2016

    Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) - Pipeline Review, H2 2016


    2016-10-31
    Global Markets Direct’s, ‘Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) - Pipeline Review, H2 2016’, provides in depth analysis on Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) targeted pipeline therapeutics....
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0639TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0639TDB
  • View Report: Research and Experts Market Report: Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD274) - Pipeline Review, H2 2016

    Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD274) - Pipeline Review, H2 2016


    2016-10-31
    Global Markets Direct’s, ‘Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD274) - Pipeline Review, H2 2016’, provides in depth analysis on Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD274) targeted pipeline therapeutics....
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0621TDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC0621TDB
  • View Report: Research and Experts Market Report: CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154...

    CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H2 2016


    2016-10-31
    Global Markets Direct’s, ‘CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H2 2016’, provides in depth analysis on CD40 Ligand...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0618TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0618TDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2016, provides an overview of the Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline landscape.

    Chronic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8731IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8731IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H2 2016

    Myelodysplastic Syndrome - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myelodysplastic Syndrome – Pipeline Review, H2 2016, provides an overview of the Myelodysplastic Syndrome (Oncology) pipeline landscape.

    Myelodysplastic syndrome...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8729IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8729IDB
  • View Report: Research and Experts Market Report: Metastatic Colorectal Cancer - Pipeline Review, H2 2016

    Metastatic Colorectal Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Colorectal Cancer – Pipeline Review, H2 2016, provides an overview of the Metastatic Colorectal Cancer (Oncology) pipeline landscape.

    Metastatic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8728IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8728IDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review, H2 2016, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8721IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8721IDB
  • View Report: Research and Experts Market Report: Follicular Lymphoma - Pipeline Review, H2 2016

    Follicular Lymphoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Follicular Lymphoma – Pipeline Review, H2 2016, provides an overview of the Follicular Lymphoma (Oncology) pipeline landscape.

    Follicular lymphoma is a common...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8717IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8717IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Metastatic...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8713IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8713IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H2 2016

    Epithelial Ovarian Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epithelial Ovarian Cancer – Pipeline Review, H2 2016, provides an overview of the Epithelial Ovarian Cancer (Oncology) pipeline landscape.

    Ovarian epithelial...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8712IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8712IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer - Pipeline Review, H2 2016

    Small-Cell Lung Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Small-Cell Lung Cancer – Pipeline Review, H2 2016, provides an overview of the Small-Cell Lung Cancer (Oncology) pipeline landscape.

    Small cell lung cancer...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8706IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8706IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016

    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Refractory Acute Myeloid Leukemia – Pipeline Review, H2 2016, provides an overview of the Refractory Acute Myeloid Leukemia (Oncology) pipeline landscape.

    The...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8705IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8705IDB
  • View Report: Research and Experts Market Report: Anorexia Nervosa Global Clinical Trials Review, H2, 2016

    Anorexia Nervosa Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Anorexia Nervosa Global Clinical Trials Review, H2, 2016" provides an overview of Anorexia Nervosa clinical trials scenario. This report provides top line data relating to the clinical trials on Anorexia...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3855CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3855CTIDB
  • View Report: Research and Experts Market Report: Cirrhosis Global Clinical Trials Review, H2, 2016

    Cirrhosis Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Cirrhosis Global Clinical Trials Review, H2, 2016" provides an overview of Cirrhosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cirrhosis. Report...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3836CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3836CTIDB
  • View Report: Research and Experts Project Profile: Bristol-Myers Squibb Company - Strategy, SWOT and Corporate Finance Report

    Bristol-Myers Squibb Company - Strategy, SWOT and Corporate Finance Report


    2016-12-21
    Bristol-Myers Squibb Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate...
  • Project Profile
  • Life Sciences
  • United States
  • $175.00
  • Report 05IK-1EADAA15-81D1-4CA2-A1A4-CC has a star rating of 4.2 out of 5
  • Go to More information on Report 05IK-1EADAA15-81D1-4CA2-A1A4-CC
  • View Report: Research and Experts Market Report: Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Pipeline Review, H2 2016

    Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct’s, ‘Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Pipeline Review, H2 2016’, provides in depth analysis on Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27)...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0617TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0617TDB
  • View Report: Research and Experts Market Report: C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide...

    C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associated Protein 3 or Stromal Cell Derived Factor 1 Receptor or NPYRL or CD184 or CXCR4) - Pipeline Review, H2


    2016-10-26
    Global Markets Direct’s, ‘C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associated Protein 3 or Stromal Cell Derived Factor 1 Receptor or NPYRL or...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0614TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0614TDB
  • View Report: Research and Experts Market Report: Tyrosine Protein Kinase BTK (Bruton Tyrosine Kinase or B Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or BTK or EC...

    Tyrosine Protein Kinase BTK (Bruton Tyrosine Kinase or B Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or BTK or EC 2.7.10.2) - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct’s, ‘Tyrosine Protein Kinase BTK (Bruton Tyrosine Kinase or B Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or BTK or EC 2.7.10.2) - Pipeline Review, H2 2016’, provides in depth analysis on Tyrosine Protein...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0612TDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC0612TDB
  • View Report: Research and Experts Market Report: Gamma Secretase (EC 3.4.23.) - Pipeline Review, H2 2016

    Gamma Secretase (EC 3.4.23.) - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct’s, ‘Gamma Secretase (EC 3.4.23.) - Pipeline Review, H2 2016’, provides in depth analysis on Gamma Secretase (EC 3.4.23.) targeted pipeline therapeutics.

    The report provides comprehensive information on the Gamma...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0603TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0603TDB
  • View Report: Research and Experts Market Report: Migraine - Pipeline Review, H2 2016

    Migraine - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Migraine – Pipeline Review, H2 2016, provides an overview of the Migraine (Central Nervous System) pipeline landscape.

    Migraine is a disorder characterized...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8702IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8702IDB
  • View Report: Research and Experts Market Report: Cervical Cancer - Pipeline Review, H2 2016

    Cervical Cancer - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cervical Cancer – Pipeline Review, H2 2016, provides an overview of the Cervical Cancer (Oncology) pipeline landscape.

    Cervical cancer occurs when abnormal...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8700IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8700IDB
  • View Report: Research and Experts Market Report: Malignant Pleural Mesothelioma - Pipeline Review, H2 2016

    Malignant Pleural Mesothelioma - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malignant Pleural Mesothelioma – Pipeline Review, H2 2016, provides an overview of the Malignant Pleural Mesothelioma (Oncology) pipeline landscape.

    Malignant...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8690IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8690IDB
  • View Report: Research and Experts Market Report: Endometrial Cancer - Pipeline Review, H2 2016

    Endometrial Cancer - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Endometrial Cancer – Pipeline Review, H2 2016, provides an overview of the Endometrial Cancer (Oncology) pipeline landscape.

    Endometrial cancer is cancer that...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8689IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8689IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2016

    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Adenocarcinoma Of The Gastroesophageal Junction – Pipeline Review, H2 2016, provides an overview of the Adenocarcinoma Of The Gastroesophageal Junction (Oncology)...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8688IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8688IDB
  • View Report: Research and Experts Market Report: Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Refractory Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2016, provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology)...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8687IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8687IDB
  • View Report: Research and Experts Market Report: Human Immunodeficiency Virus (HIV) Infections (AIDS) Global Clinical Trials Review, H2, 2016

    Human Immunodeficiency Virus (HIV) Infections (AIDS) Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Human Immunodeficiency Virus (HIV) Infections (AIDS) Global Clinical Trials Review, H2, 2016" provides an overview of Human Immunodeficiency Virus (HIV) Infections (AIDS) clinical trials scenario. This...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3831CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3831CTIDB
  • View Report: Research and Experts Market Report: Granulomatosis with Polyangiitis (Wegener Polyangiitis) Global Clinical Trials Review, H2, 2016

    Granulomatosis with Polyangiitis (Wegener Polyangiitis) Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Granulomatosis with Polyangiitis (Wegener Polyangiitis) Global Clinical Trials Review, H2, 2016" provides an overview of Granulomatosis with Polyangiitis (Wegener Polyangiitis) clinical trials scenario....
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3829CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3829CTIDB
  • View Report: Research and Experts Market Report: Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016

    Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016" provides an overview of Kidney Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3820CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3820CTIDB
  • View Report: Research and Experts Market Report: Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2016

    Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct’s, ‘Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2016’, provides in depth analysis on Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0599TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0599TDB
  • View Report: Research and Experts Market Report: Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or...

    Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or OX40L Receptor or CD134 or TNFRSF4) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct’s, ‘Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or OX40L Receptor or CD134 or TNFRSF4) - Pipeline Review, H2 2016’, provides in depth...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0588TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0588TDB
  • View Report: Research and Experts Market Report: Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or...

    Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct’s, ‘Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) - Pipeline Review, H2 2016’, provides in depth analysis on Tumor Necrosis...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0587TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0587TDB
  • View Report: Research and Experts Market Report: Renal Cell Carcinoma - Pipeline Review, H2 2016

    Renal Cell Carcinoma - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Renal Cell Carcinoma – Pipeline Review, H2 2016, provides an overview of the Renal Cell Carcinoma (Oncology) pipeline landscape.

    Renal cell carcinoma (RCC,...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8682IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8682IDB
  • View Report: Research and Experts Market Report: Psoriatic Arthritis - Pipeline Review, H2 2016

    Psoriatic Arthritis - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriatic Arthritis – Pipeline Review, H2 2016, provides an overview of the Psoriatic Arthritis (Musculoskeletal Disorders) pipeline landscape.

    Psoriatic arthritis...

  • Market Report
  • Musculoskeletal Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8680IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8680IDB
  • View Report: Research and Experts Market Report: Thrombocytopenia - Pipeline Review, H2 2016

    Thrombocytopenia - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thrombocytopenia – Pipeline Review, H2 2016, provides an overview of the Thrombocytopenia (Hematological Disorders) pipeline landscape.

    Thrombocytopenia is...

  • Market Report
  • Hematological Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8676IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8676IDB
  • View Report: Research and Experts Market Report: Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Relapsed Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2016, provides an overview of the Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8673IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8673IDB
  • View Report: Research and Experts Market Report: Systemic Mastocytosis - Pipeline Review, H2 2016

    Systemic Mastocytosis - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Mastocytosis – Pipeline Review, H2 2016, provides an overview of the Systemic Mastocytosis (Gastrointestinal) pipeline landscape.

    Systemic mastocytosis...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8648IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8648IDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Lymphocytic Leukemia – Pipeline Review, H2 2016, provides an overview of the Acute Lymphocytic Leukemia (Oncology) pipeline landscape.

    Acute lymphocytic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8640IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8640IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H2 2016

    Systemic Lupus Erythematosus - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Lupus Erythematosus – Pipeline Review, H2 2016, provides an overview of the Systemic Lupus Erythematosus (Immunology) pipeline landscape.

    Systemic...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8637IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8637IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer Global Clinical Trials Review, H2, 2016

    Non-Small Cell Lung Cancer Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Non-Small Cell Lung Cancer clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3815CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3815CTIDB
  • View Report: Research and Experts Market Report: Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Global Clinical Trials Review, H2, 2016

    Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Global Clinical Trials Review, H2, 2016" provides an overview of Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) clinical trials scenario. This report provides top...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3814CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3814CTIDB
  • View Report: Research and Experts Market Report: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H2, 2016

    Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H2, 2016" provides an overview of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3812CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3812CTIDB
  • View Report: Research and Experts Market Report: Left Ventricular Hypertrophy Global Clinical Trials Review, H2, 2016

    Left Ventricular Hypertrophy Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Left Ventricular Hypertrophy Global Clinical Trials Review, H2, 2016" provides an overview of Left Ventricular Hypertrophy clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3807CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3807CTIDB
  • View Report: Research and Experts Market Report: Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2016

    Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2016" provides an overview of Focal Segmental Glomerulosclerosis (FSGS) clinical trials scenario. This report provides top...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3803CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3803CTIDB
  • View Report: Research and Experts Market Report: AIDS Associated Dementia Global Clinical Trials Review, H2, 2016

    AIDS Associated Dementia Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “AIDS Associated Dementia Global Clinical Trials Review, H2, 2016" provides an overview of AIDS Associated Dementia clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3799CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3799CTIDB
  • View Report: Research and Experts Market Report: Kaposi Sarcoma Global Clinical Trials Review, H2, 2016

    Kaposi Sarcoma Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Kaposi Sarcoma Global Clinical Trials Review, H2, 2016" provides an overview of Kaposi Sarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Kaposi Sarcoma....
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3795CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3795CTIDB
  • View Report: Research and Experts Market Report: Sphingosine 1 Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor...

    Sphingosine 1 Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct’s, ‘Sphingosine 1 Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) – Pipeline Review, - Pipeline Review, H2 2016’, provides...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0585TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0585TDB
  • View Report: Research and Experts Market Report: Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Pipeline Review, H2 2016

    Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct’s, ‘Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Pipeline Review, H2 2016’, provides in depth analysis on Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) targeted pipeline therapeutics....
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0584TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0584TDB
  • View Report: Research and Experts Market Report: C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1 Alpha Receptor or RANTES R or CD191 or...

    C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1 Alpha Receptor or RANTES R or CD191 or CCR1) - Pipeline Review, H2 2016


    2016-09-30
    Global Markets Direct’s, ‘C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1 Alpha Receptor or RANTES R or CD191 or CCR1) - Pipeline Review, H2 2016’, provides in depth analysis on C-C Chemokine...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0567TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0567TDB
  • View Report: Research and Experts Market Report: Schizophrenia - Pipeline Review, H2 2016

    Schizophrenia - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia – Pipeline Review, H2 2016, provides an overview of the Schizophrenia (Central Nervous System) pipeline landscape.

    Schizophrenia is a chronic,...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8727IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8727IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016

    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer Squamous Cell Carcinoma – Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer Squamous Cell Carcinoma (Oncology)...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8644IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8644IDB
  • View Report: Research and Experts Market Report: Gliosarcoma - Pipeline Review, H2 2016

    Gliosarcoma - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gliosarcoma – Pipeline Review, H2 2016, provides an overview of the Gliosarcoma (Oncology) pipeline landscape.

    Gliosarcoma is a type of brain tumor that originates...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8633IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8633IDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H2 2016

    Bladder Cancer - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer – Pipeline Review, H2 2016, provides an overview of the Bladder Cancer (Oncology) pipeline landscape.

    Bladder cancer occurs in tissues of the...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8622IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8622IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H2 2016

    Type 2 Diabetes - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes – Pipeline Review, H2 2016, provides an overview of the Type 2 Diabetes (Metabolic Disorders) pipeline landscape.

    Type 2 diabetes is a chronic...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8585IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8585IDB
  • View Report: Research and Experts Market Report: PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

    PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025


    2016-08-08
    Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality in the world. The term acute coronary syndrome (ACS) applies to a spectrum of acute CVD states that are precipitated by coronary artery occlusi...
  • Market Report
  • Automotive
  • Global
  • $10,995.00
  • Report 05IC-GDHC131PIDR has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC131PIDR
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2016

    Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diffuse Large B-Cell Lymphoma – Pipeline Review, H2 2016, provides an overview of the Diffuse Large B-Cell Lymphoma (Oncology) pipeline landscape.

    Diffuse large...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8656IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8656IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide B-Cell Non-Hodgkin Lymphoma – Pipeline Review, H2 2016, provides an overview of the B-Cell Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

    Non-Hodgkin lymphoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8609IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8609IDB
  • View Report: Research and Experts Market Report: Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2016

    Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic Pulmonary Fibrosis – Pipeline Review, H2 2016, provides an overview of the Idiopathic Pulmonary Fibrosis (Respiratory) pipeline landscape.

    Idiopathic...

  • Market Report
  • Respiratory
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8608IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8608IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Relapsed Acute Myeloid Leukemia – Pipeline Review, H2 2016, provides an overview of the Relapsed Acute Myeloid Leukemia (Oncology) pipeline landscape.

    Return...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8605IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8605IDB
  • View Report: Research and Experts Market Report: Sickle Cell Disease - Pipeline Review, H2 2016

    Sickle Cell Disease - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sickle Cell Disease – Pipeline Review, H2 2016, provides an overview of the Sickle Cell Disease (Hematological Disorders) pipeline landscape.

    Sickle cell anemia...

  • Market Report
  • Hematological Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8604IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8604IDB
  • View Report: Research and Experts Market Report: Ulcerative Colitis - Pipeline Review, H2 2016

    Ulcerative Colitis - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ulcerative Colitis – Pipeline Review, H2 2016, provides an overview of the Ulcerative Colitis (Gastrointestinal) pipeline landscape.

    Ulcerative Colitis (Colitis...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8598IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8598IDB
  • View Report: Research and Experts Market Report: Vitiligo - Pipeline Review, H2 2016

    Vitiligo - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vitiligo – Pipeline Review, H2 2016, provides an overview of the Vitiligo (Dermatology) pipeline landscape.

    Vitiligo is a condition in which skin loses melanin,...

  • Market Report
  • Dermatology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8592IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8592IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer - Pipeline Review, H2 2016

    Head And Neck Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer – Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape.

    Head and Neck Cancer is a cancer...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8588IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8588IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H2 2016

    Gastric Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer – Pipeline Review, H2 2016, provides an overview of the Gastric Cancer (Oncology) pipeline landscape.

    Gastric cancer, also called stomach cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8584IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8584IDB
  • View Report: Research and Experts Market Report: Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016

    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Recurrent Glioblastoma Multiforme (GBM) – Pipeline Review, H2 2016, provides an overview of the Recurrent Glioblastoma Multiforme (GBM) (Oncology) pipeline landscape....
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8562IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8562IDB
  • View Report: Research and Experts Market Report: Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016

    Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Plaque Psoriasis (Psoriasis Vulgaris) – Pipeline Review, H2 2016, provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) (Immunology) pipeline landscape.

    ...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8559IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8559IDB
  • View Report: Research and Experts Market Report: Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2016

    Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Kidney Disease (Chronic Renal Failure) – Pipeline Review, H2 2016, provides an overview of the Chronic Kidney Disease (Chronic Renal Failure) (Genito...
  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8538IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8538IDB
  • View Report: Research and Experts Market Report: Major Depressive Disorder - Pipeline Review, H2 2016

    Major Depressive Disorder - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Major Depressive Disorder – Pipeline Review, H2 2016, provides an overview of the Major Depressive Disorder (Central Nervous System) pipeline landscape.

    Major...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8535IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8535IDB
  • View Report: Research and Experts Market Report: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hormone Refractory Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Hormone Refractory Prostate Cancer (Oncology) pipeline landscape.

    Prostate...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8504IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8504IDB
  • View Report: Research and Experts Market Report: Uveitis - Pipeline Review, H2 2016

    Uveitis - Pipeline Review, H2 2016


    2016-09-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Uveitis – Pipeline Review, H2 2016, provides an overview of the Uveitis (Ophthalmology) pipeline landscape.

    Uveitis is swelling and irritation of the uvea,...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8544IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8544IDB
  • View Report: Research and Experts Market Report: Hepatitis C - Pipeline Review, H2 2016

    Hepatitis C - Pipeline Review, H2 2016


    2016-09-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis C – Pipeline Review, H2 2016, provides an overview of the Hepatitis C (Infectious Disease) pipeline landscape.

    Hepatitis C is a contagious viral infection...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8516IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8516IDB
  • View Report: Research and Experts Market Report: Oropharyngeal Candidiasis Global Clinical Trials Review, H2, 2016

    Oropharyngeal Candidiasis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Oropharyngeal Candidiasis Global Clinical Trials Review, H2, 2016" provides an overview of Oropharyngeal Candidiasis clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3774CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3774CTIDB
  • View Report: Research and Experts Market Report: Ischemic Stroke Global Clinical Trials Review, H2, 2016

    Ischemic Stroke Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Ischemic Stroke Global Clinical Trials Review, H2, 2016" provides an overview of Ischemic Stroke clinical trials scenario. This report provides top line data relating to the clinical trials on Ischemic...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3757CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3757CTIDB
  • View Report: Research and Experts Market Report: Atrial Fibrillation Global Clinical Trials Review, H2, 2016

    Atrial Fibrillation Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Atrial Fibrillation Global Clinical Trials Review, H2, 2016" provides an overview of Atrial Fibrillation clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3754CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3754CTIDB
  • View Report: Research and Experts Market Report: Acute Coronary Syndrome Global Clinical Trials Review, H2, 2016

    Acute Coronary Syndrome Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Acute Coronary Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Acute Coronary Syndrome clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3750CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3750CTIDB
  • View Report: Research and Experts Market Report: Pulmonary Fibrosis Global Clinical Trials Review, H2, 2016

    Pulmonary Fibrosis Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Pulmonary Fibrosis Global Clinical Trials Review, H2, 2016" provides an overview of Pulmonary Fibrosis clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Respiratory
  • Global
  • $2,500.00
  • Report 05IC-GDHC3749CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3749CTIDB
  • View Report: Research and Experts Market Report: PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

    PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025


    2016-08-01
    Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregular and often abnormally fast heart rate. Various therapeutic options are available to treat patients with AF, and most patients will receive...
  • Market Report
  • Automotive
  • Global
  • $10,995.00
  • Report 05IC-GDHC133PIDR has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC133PIDR
  • View Report: Research and Experts Market Report: PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

    PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025


    2016-08-01
    Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from pulmonary embolism (PE) to deep vein thrombosis (DVT. The condition is relatively prevalent and is associated with long-term mortality and morbidit...
  • Market Report
  • Automotive
  • Global
  • $10,995.00
  • Report 05IC-GDHC132PIDR has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC132PIDR
  • View Report: Research and Experts Market Report: Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor...

    Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor C or Retinoid Related Orphan Receptor Gamma or RORC) - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor C or Retinoid Related Orphan Receptor Gamma or RORC) - Pipeline Review, H2 2016’,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0548TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0548TDB
  • View Report: Research and Experts Market Report: N-Formyl Peptide Receptor 2 (FMLP Related Receptor I or Formyl Peptide Receptor Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2)...

    N-Formyl Peptide Receptor 2 (FMLP Related Receptor I or Formyl Peptide Receptor Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘N-Formyl Peptide Receptor 2 (FMLP Related Receptor I or Formyl Peptide Receptor Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Pipeline Review, H2 2016’, provides in depth analysis on N-Formyl Peptide...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0545TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0545TDB
  • View Report: Research and Experts Market Report: Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg 2 or LPAR1) - Pipeline Review, H2 2016

    Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg 2 or LPAR1) - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg 2 or LPAR1) - Pipeline Review, H2 2016’, provides in depth analysis on Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg 2...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0541TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0541TDB
  • View Report: Research and Experts Market Report: Psoriasis - Pipeline Review, H2 2016

    Psoriasis - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H2 2016’, provides an overview of the Psoriasis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Psoriasis, complete with...

  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8494IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8494IDB
  • View Report: Research and Experts Market Report: Lupus Nephritis - Pipeline Review, H2 2016

    Lupus Nephritis - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Lupus Nephritis - Pipeline Review, H2 2016’, provides an overview of the Lupus Nephritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Lupus Nephritis,...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8490IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8490IDB
  • View Report: Research and Experts Market Report: Pulmonary Fibrosis - Pipeline Review, H2 2016

    Pulmonary Fibrosis - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Pulmonary Fibrosis - Pipeline Review, H2 2016’, provides an overview of the Pulmonary Fibrosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Pulmonary...

  • Market Report
  • Respiratory
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8475IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8475IDB
  • View Report: Research and Experts Market Report: Metastatic Melanoma - Pipeline Review, H2 2016

    Metastatic Melanoma - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H2 2016’, provides an overview of the Metastatic Melanoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Metastatic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8473IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8473IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016

    Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016" provides an overview of Multiple Myeloma (Kahler Disease) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3734CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3734CTIDB
  • View Report: Research and Experts Market Report: Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H2, 2016

    Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H2, 2016" provides an overview of Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) clinical trials scenario. This report...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3730CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3730CTIDB
  • View Report: Research and Experts Market Report: Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2016

    Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2016" provides an overview of Lymphoblastic Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3726CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3726CTIDB
  • View Report: Research and Experts Market Report: Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2016

    Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2016" provides an overview of Relapsed Multiple Myeloma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3725CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3725CTIDB
  • View Report: Research and Experts Market Report: Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H2, 2016

    Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H2, 2016" provides an overview of Transitional Cell Cancer (Urothelial Cell Cancer) clinical trials scenario. This report...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3724CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3724CTIDB
  • View Report: Research and Experts Market Report: Malignant Pleural Mesothelioma Global Clinical Trials Review, H2, 2016

    Malignant Pleural Mesothelioma Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Malignant Pleural Mesothelioma Global Clinical Trials Review, H2, 2016" provides an overview of Malignant Pleural Mesothelioma clinical trials scenario. This report provides top line data relating to...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3721CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3721CTIDB
  • View Report: Research and Experts Market Report: HER2-Negative Breast Cancer - Current and Future Players

    HER2-Negative Breast Cancer - Current and Future Players


    2015-01-31
    GlobalData has released its pharma report, “HER2-Negative Breast Cancer - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Insomnia Market. The...
  • Market Report
  • Oncology
  • Global
  • $2,995.00
  • Report 05IC-GDHC1063FPR has a star rating of 3.7 out of 5
  • Go to More information on Report 05IC-GDHC1063FPR
  • View Report: Research and Experts Market Report: Juvenile Rheumatoid Arthritis Global Clinical Trials Review, H2, 2016

    Juvenile Rheumatoid Arthritis Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Juvenile Rheumatoid Arthritis Global Clinical Trials Review, H2, 2016" provides an overview of Juvenile Rheumatoid Arthritis clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3702CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3702CTIDB
  • View Report: Research and Experts Market Report: Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) Global Clinical Trials Review, H2, 2016

    Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) Global Clinical Trials Review, H2, 2016" provides an overview of Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) clinical trials scenario. This...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3701CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3701CTIDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2016

    Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2016" provides an overview of Systemic Lupus Erythematosus clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3699CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3699CTIDB
  • View Report: Research and Experts Market Report: Lupus Erythematosus Global Clinical Trials Review, H2, 2016

    Lupus Erythematosus Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Lupus Erythematosus Global Clinical Trials Review, H2, 2016" provides an overview of Lupus Erythematosus clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3694CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3694CTIDB
  • View Report: Research and Experts Market Report: Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Pipeline Review, H2 2016

    Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Pipeline Review, H2 2016’, provides in depth analysis on Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) targeted pipeline...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0525TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0525TDB
  • View Report: Research and Experts Market Report: Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2016

    Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2016’, provides an overview of the Graft Versus Host Disease (GVHD) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8464IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8464IDB
  • View Report: Research and Experts Market Report: Liver Fibrosis - Pipeline Review, H2 2016

    Liver Fibrosis - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Liver Fibrosis - Pipeline Review, H2 2016’, provides an overview of the Liver Fibrosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Liver Fibrosis,...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8453IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8453IDB
  • View Report: Research and Experts Market Report: Arterial Thrombosis - Pipeline Review, H2 2016

    Arterial Thrombosis - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Arterial Thrombosis - Pipeline Review, H2 2016’, provides an overview of the Arterial Thrombosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Arterial...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8444IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8444IDB
  • View Report: Research and Experts Market Report: Galectin 3 (35 kDa Lectin or Carbohydrate Binding Protein 35 or Galactose Specific Lectin 3 or Galactoside Binding Protein or IgE...

    Galectin 3 (35 kDa Lectin or Carbohydrate Binding Protein 35 or Galactose Specific Lectin 3 or Galactoside Binding Protein or IgE Binding Protein or Laminin Binding Proteinor Mac 2 Antigen or LGALS3) - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Galectin 3 (35 kDa Lectin or Carbohydrate Binding Protein 35 or Galactose Specific Lectin 3 or Galactoside Binding Protein or IgE Binding Protein or Laminin Binding Proteinor Mac 2 Antigen or LGALS3) - Pipeline Review,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0506TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0506TDB
  • View Report: Research and Experts Market Report: Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H2 2016

    Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H2 2016’, provides in depth analysis on Protein Phosphatase 2A (PP2A or EC 3.1.3.16) targeted pipeline therapeutics.

    The report provides comprehensive...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0455TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0455TDB
  • View Report: Research and Experts Market Report: Bone Marrow Transplant Rejection - Pipeline Review, H2 2016

    Bone Marrow Transplant Rejection - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Bone Marrow Transplant Rejection - Pipeline Review, H2 2016’, provides an overview of the Bone Marrow Transplant Rejection pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8428IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8428IDB
  • View Report: Research and Experts Market Report: Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016

    Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2016’, provides an overview of the Congestive Heart Failure (Heart Failure) pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8423IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8423IDB
  • View Report: Research and Experts Market Report: Melanoma - Current and Future Players

    Melanoma - Current and Future Players


    2015-04-05
    GlobalData has released its pharma report, “Melanoma - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Melanoma Market. The report identifies...
  • Market Report
  • Oncology
  • Global
  • $2,995.00
  • Report 05IC-GDHC1059FPR has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC1059FPR
  • View Report: Research and Experts Market Report: Sepsis Global Clinical Trials Review, H2, 2016

    Sepsis Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Sepsis Global Clinical Trials Review, H2, 2016" provides an overview of Sepsis clinical trials scenario. This report provides top line data relating to the clinical trials on Sepsis. Report includes...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3686CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3686CTIDB
  • View Report: Research and Experts Market Report: Anthrax Global Clinical Trials Review, H2, 2016

    Anthrax Global Clinical Trials Review, H2, 2016


    2016-08-24
    GlobalData's clinical trial report, “Anthrax Global Clinical Trials Review, H2, 2016" provides an overview of Anthrax clinical trials scenario. This report provides top line data relating to the clinical trials on Anthrax. Report includes...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3665CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3665CTIDB
  • View Report: Research and Experts Market Report: Hepatitis B Global Clinical Trials Review, H2, 2016

    Hepatitis B Global Clinical Trials Review, H2, 2016


    2016-08-24
    GlobalData's clinical trial report, “Hepatitis B Global Clinical Trials Review, H2, 2016" provides an overview of Hepatitis B clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis B. Report...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3663CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3663CTIDB
  • View Report: Research and Experts Market Report: Hepatitis C Global Clinical Trials Review, H2, 2016

    Hepatitis C Global Clinical Trials Review, H2, 2016


    2016-08-24
    GlobalData's clinical trial report, “Hepatitis C Global Clinical Trials Review, H2, 2016" provides an overview of Hepatitis C clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis C. Report...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3662CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3662CTIDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016

    Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016


    2016-08-24
    GlobalData's clinical trial report, “Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016" provides an overview of Glioblastoma Multiforme (GBM) clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3658CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3658CTIDB
  • View Report: Research and Experts Market Report: Tryptophan 2,3 Dioxygenase (Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or...

    Tryptophan 2,3 Dioxygenase (Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11) - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Tryptophan 2,3 Dioxygenase (Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11) - Pipeline Review, H2 2016’, provides in depth analysis on Tryptophan...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0488TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0488TDB
  • View Report: Research and Experts Market Report: Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2016

    Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2016’, provides an overview of the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) pipeline landscape....
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8392IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8392IDB
  • View Report: Research and Experts Market Report: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) - Pipeline Review, H2 2016

    Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) - Pipeline Review, H2 2016’, provides an overview of the Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis)...
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8386IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8386IDB
  • View Report: Research and Experts Market Report: Polycythemia Vera - Pipeline Review, H2 2016

    Polycythemia Vera - Pipeline Review, H2 2016


    2016-08-17
    Global Markets Direct’s, ‘Polycythemia Vera - Pipeline Review, H2 2016’, provides an overview of the Polycythemia Vera pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Polycythemia...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8360IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8360IDB
  • View Report: Research and Experts Market Report: Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Pipeline Review, H2 2016

    Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Pipeline Review, H2 2016’, provides in depth analysis on Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0456TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0456TDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H2 2016’, provides an overview of the Alzheimer's Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8356IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8356IDB
  • View Report: Research and Experts Market Report: Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2016

    Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2016’, provides an overview of the Metastatic Renal Cell Carcinoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8355IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8355IDB
  • View Report: Research and Experts Market Report: Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2016

    Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2016’, provides an overview of the Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8349IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8349IDB
  • View Report: Research and Experts Market Report: Mantle Cell Lymphoma - Pipeline Review, H2 2016

    Mantle Cell Lymphoma - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H2 2016’, provides an overview of the Mantle Cell Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Mantle...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8348IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8348IDB
  • View Report: Research and Experts Market Report: Duchenne Muscular Dystrophy - Pipeline Review, H2 2016

    Duchenne Muscular Dystrophy - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Duchenne Muscular Dystrophy - Pipeline Review, H2 2016’, provides an overview of the Duchenne Muscular Dystrophy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Genetic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8342IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8342IDB
  • View Report: Research and Experts Market Report: Indolent Lymphoma - Pipeline Review, H2 2016

    Indolent Lymphoma - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H2 2016’, provides an overview of the Indolent Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Indolent...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8340IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8340IDB
  • View Report: Research and Experts Market Report: Atrial Fibrillation - Pipeline Review, H2 2016

    Atrial Fibrillation - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Atrial Fibrillation - Pipeline Review, H2 2016’, provides an overview of the Atrial Fibrillation pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Atrial...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8335IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8335IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma - Current and Future Players

    Multiple Myeloma - Current and Future Players


    2015-11-01
    GlobalData has released its pharma report, “Multiple Myeloma - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Multiple Myeloma Market. The report...
  • Market Report
  • Oncology
  • Global
  • $2,995.00
  • Report 05IC-GDHC1051FPR has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC1051FPR
  • View Report: Research and Experts Market Report: Systolic Hypertension Global Clinical Trials Review, H2, 2016

    Systolic Hypertension Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Systolic Hypertension Global Clinical Trials Review, H2, 2016" provides an overview of Systolic Hypertension clinical trials scenario. This report provides top line data relating to the clinical trials on Systolic Hypertension...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3608CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3608CTIDB
  • View Report: Research and Experts Market Report: Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2016

    Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2016" provides an overview of Occlusive Coronary Artery Disease clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3602CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3602CTIDB
  • View Report: Research and Experts Market Report: Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2016

    Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2016" provides an overview of Ischemic Cardiomyopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Ischemic...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3599CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3599CTIDB
  • View Report: Research and Experts Market Report: Atherosclerosis Global Clinical Trials Review, H2, 2016

    Atherosclerosis Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Atherosclerosis Global Clinical Trials Review, H2, 2016" provides an overview of Atherosclerosis clinical trials scenario. This report provides top line data relating to the clinical trials on Atherosclerosis. Report...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3587CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3587CTIDB
  • View Report: Research and Experts Market Report: Coronary Stenosis Global Clinical Trials Review, H2, 2016

    Coronary Stenosis Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Coronary Stenosis Global Clinical Trials Review, H2, 2016" provides an overview of Coronary Stenosis clinical trials scenario. This report provides top line data relating to the clinical trials on Coronary Stenosis. Report...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3584CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3584CTIDB
  • View Report: Research and Experts Market Report: Arteriosclerosis Global Clinical Trials Review, H2, 2016

    Arteriosclerosis Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Arteriosclerosis Global Clinical Trials Review, H2, 2016" provides an overview of Arteriosclerosis clinical trials scenario. This report provides top line data relating to the clinical trials on Arteriosclerosis. Report...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3583CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3583CTIDB
  • View Report: Research and Experts Market Report: Aortic Valve Stenosis Global Clinical Trials Review, H2, 2016

    Aortic Valve Stenosis Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Aortic Valve Stenosis Global Clinical Trials Review, H2, 2016" provides an overview of Aortic Valve Stenosis clinical trials scenario. This report provides top line data relating to the clinical trials on Aortic Valve...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3582CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3582CTIDB
  • View Report: Research and Experts Market Report: Schizoaffective Disorder Global Clinical Trials Review, H2, 2016

    Schizoaffective Disorder Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Schizoaffective Disorder Global Clinical Trials Review, H2, 2016" provides an overview of Schizoaffective Disorder clinical trials scenario. This report provides top line data relating to the clinical trials on Schizoaffective...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3574CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3574CTIDB
  • View Report: Research and Experts Market Report: Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Pipeline Review, H2 2016

    Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Pipeline Review, H2 2016


    2016-07-27
    ‘Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Pipeline Review, H2 2016’, provides in depth analysis on Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) targeted pipeline therapeutics.

    The report...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0417TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0417TDB
  • View Report: Research and Experts Market Report: Tyrosine Protein Kinase Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kinase or p59 Fyn or FYN or EC 2.7.10.2) - Pipeline...

    Tyrosine Protein Kinase Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kinase or p59 Fyn or FYN or EC 2.7.10.2) - Pipeline Review, H2 2016


    2016-07-20
    ‘Tyrosine Protein Kinase Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kinase or p59 Fyn or FYN or EC 2.7.10.2) - Pipeline Review, H2 2016’, provides in depth analysis on Tyrosine Protein Kinase Fyn (Proto Oncogene Syn or Proto...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0402TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0402TDB
  • View Report: Research and Experts Market Report: Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Pipeline Review, H2 2016

    Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Pipeline Review, H2 2016


    2016-07-20
    ‘Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Pipeline Review, H2 2016’, provides in depth analysis on Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2)...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0401TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0401TDB
  • View Report: Research and Experts Market Report: Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Pipeline Review, H2 2016

    Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Pipeline Review, H2 2016


    2016-07-20
    ‘Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Pipeline Review, H2 2016’, provides in depth analysis on Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) targeted pipeline therapeutics.

    The report...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0400TDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC0400TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2016

    Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-07-20
    ‘Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) targeted pipeline therapeutics.

    The report...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0398TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0398TDB
  • View Report: Research and Experts Market Report: Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2016

    Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2016


    2016-07-27
    ‘Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2016’, provides an overview of the Systemic Sclerosis (Scleroderma) pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Systemic...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8302IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8302IDB
  • View Report: Research and Experts Market Report: Colitis - Pipeline Review, H2 2016

    Colitis - Pipeline Review, H2 2016


    2016-07-27
    ‘Colitis - Pipeline Review, H2 2016’, provides an overview of the Colitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Colitis, complete with analysis by stage of development,...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8309IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8309IDB
  • View Report: Research and Experts Market Report: Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2016

    Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2016


    2016-07-20
    ‘Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2016’, provides an overview of the Non-Alcoholic Steatohepatitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Non-Alcoholic...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8327IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8327IDB
  • View Report: Research and Experts Market Report: Alopecia - Pipeline Review, H2 2016

    Alopecia - Pipeline Review, H2 2016


    2016-07-20
    ‘Alopecia - Pipeline Review, H2 2016’, provides an overview of the Alopecia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Alopecia, complete with analysis by stage of development,...

  • Market Report
  • Dermatology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8292IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8292IDB
  • View Report: Research and Experts Market Report: Diabetic Neuropathic Pain - Pipeline Review, H2 2016

    Diabetic Neuropathic Pain - Pipeline Review, H2 2016


    2016-07-27
    ‘Diabetic Neuropathic Pain - Pipeline Review, H2 2016’, provides an overview of the Diabetic Neuropathic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Diabetic Neuropathic...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8307IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8307IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2016

    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2016


    2016-07-20
    ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2016’, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8297IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8297IDB
  • View Report: Research and Experts Market Report: T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H2 2016

    T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H2 2016’, provides in depth analysis on T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) targeted pipeline therapeutics.

    The...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0384TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0384TDB
  • View Report: Research and Experts Market Report: Tyrosine Protein Kinase Lck (Leukocyte C Terminal Src Kinase or Protein YT16 or Proto Oncogene Lck or T Cell Specific Protein Tyrosine...

    Tyrosine Protein Kinase Lck (Leukocyte C Terminal Src Kinase or Protein YT16 or Proto Oncogene Lck or T Cell Specific Protein Tyrosine Kinase or Lymphocyte Cell Specific Protein Tyrosine Kinase or p56 LCK or LCK or EC 2.7.10.2) - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘Tyrosine Protein Kinase Lck (Leukocyte C Terminal Src Kinase or Protein YT16 or Proto Oncogene Lck or T Cell Specific Protein Tyrosine Kinase or Lymphocyte Cell Specific Protein Tyrosine Kinase or p56 LCK or LCK or...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0383TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0383TDB
  • View Report: Research and Experts Market Report: Sepsis - Pipeline Review, H2 2016

    Sepsis - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘Sepsis - Pipeline Review, H2 2016’, provides an overview of the Sepsis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Sepsis, complete with analysis...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8220IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8220IDB
  • View Report: Research and Experts Market Report: Encephalomyelitis Global Clinical Trials Review, H1, 2016

    Encephalomyelitis Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Encephalomyelitis Global Clinical Trials Review, H1, 2016" provides an overview of Encephalomyelitis clinical trials scenario. This report provides top line data relating to the clinical trials on Encephalomyelitis. Report...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3524CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3524CTIDB
  • View Report: Research and Experts Market Report: Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) - Pipeline...

    Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides in depth analysis on Macrophage Stimulating Protein...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0265TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0265TDB
  • View Report: Research and Experts Market Report: Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage...

    Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2) - Pipeline Review, H1 2016’, provides...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0255TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0255TDB
  • View Report: Research and Experts Market Report: Non-Receptor Tyrosine-Protein Kinase TYK2 (Tyrosine Kinase 2 or EC 2.7.10.2) - Pipeline Review, H1 2016

    Non-Receptor Tyrosine-Protein Kinase TYK2 (Tyrosine Kinase 2 or EC 2.7.10.2) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Non-Receptor Tyrosine-Protein Kinase TYK2 (Tyrosine Kinase 2 or EC 2.7.10.2) - Pipeline Review, H1 2016’, provides in depth analysis on Non-Receptor Tyrosine-Protein Kinase TYK2 (Tyrosine Kinase 2 or EC 2.7.10.2)...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0233TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0233TDB
  • View Report: Research and Experts Market Report: Ephrin Type A Receptor 2 (Epithelial Cell Kinase or Tyrosine Protein Kinase Receptor ECK or EPHA2 or EC 2.7.10.1) - Pipeline Review,...

    Ephrin Type A Receptor 2 (Epithelial Cell Kinase or Tyrosine Protein Kinase Receptor ECK or EPHA2 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Ephrin Type A Receptor 2 (Epithelial Cell Kinase or Tyrosine Protein Kinase Receptor ECK or EPHA2 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides in depth analysis on Ephrin Type A Receptor 2 (Epithelial...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0229TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0229TDB
  • View Report: Research and Experts Market Report: Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H1 2016

    Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides in depth analysis on Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) targeted pipeline...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0228TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0228TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0225TDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC0225TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0224TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0224TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c...

    Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0223TDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC0223TDB
  • View Report: Research and Experts Market Report: Glutamate Receptor Ionotropic NMDA 2B ( NMDA Receptor Subunit Epsilon 2 or GRIN2B) - Pipeline Review, H1 2016

    Glutamate Receptor Ionotropic NMDA 2B ( NMDA Receptor Subunit Epsilon 2 or GRIN2B) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Glutamate Receptor Ionotropic NMDA 2B ( NMDA Receptor Subunit Epsilon 2 or GRIN2B) - Pipeline Review, H1 2016’, provides in depth analysis on Glutamate Receptor Ionotropic NMDA 2B ( NMDA Receptor Subunit Epsilon...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0191TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0191TDB
  • View Report: Research and Experts Market Report: Glucocorticoid Induced Tumor Necrosis Factor Receptor (Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related...

    Glucocorticoid Induced Tumor Necrosis Factor Receptor (Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Glucocorticoid Induced Tumor Necrosis Factor Receptor (Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) - Pipeline Review, H1 2016’, provides in depth...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0185TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0185TDB
  • View Report: Research and Experts Market Report: Potassium Voltage Gated Channel Subfamily A Member 5 (Voltage Gated Potassium Channel Subunit Kv1.5 or KCNA5) - Pipeline Review,...

    Potassium Voltage Gated Channel Subfamily A Member 5 (Voltage Gated Potassium Channel Subunit Kv1.5 or KCNA5) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Potassium Voltage Gated Channel Subfamily A Member 5 (Voltage Gated Potassium Channel Subunit Kv1.5 or KCNA5) - Pipeline Review, H1 2016’, provides in depth analysis on Potassium Voltage Gated Channel Subfamily...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0150TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0150TDB
  • View Report: Research and Experts Market Report: Oxysterols Receptor LXR-Beta (Liver X Receptor Beta or Nuclear Receptor NER or Nuclear Receptor Subfamily 1 Group H Member 2 or NR1H2...

    Oxysterols Receptor LXR-Beta (Liver X Receptor Beta or Nuclear Receptor NER or Nuclear Receptor Subfamily 1 Group H Member 2 or NR1H2 or LXRB) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Oxysterols Receptor LXR-Beta (Liver X Receptor Beta or Nuclear Receptor NER or Nuclear Receptor Subfamily 1 Group H Member 2 or NR1H2 or LXRB) - Pipeline Review, H1 2016’, provides in depth analysis on Oxysterols...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0097TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0097TDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7960IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7960IDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H1 2016

    Colorectal Cancer - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2016’, provides an overview of the Colorectal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Colorectal...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7959IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7959IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H1 2016

    Melanoma - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Melanoma - Pipeline Review, H1 2016’, provides an overview of the Melanoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Melanoma, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7955IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7955IDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H1 2016

    Breast Cancer - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Breast Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Breast Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7666IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7666IDB
  • View Report: Research and Experts Market Report: Lipodystrophy Global Clinical Trials Review, H1, 2016

    Lipodystrophy Global Clinical Trials Review, H1, 2016


    2016-06-30
    GlobalData's clinical trial report, “Lipodystrophy Global Clinical Trials Review, H1, 2016" provides an overview of Lipodystrophy clinical trials scenario. This report provides top line data relating to the clinical trials on Lipodystrophy....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3510CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3510CTIDB
  • View Report: Research and Experts Market Report: E3 Ubiquitin-Protein Ligase XIAP (Baculoviral IAP Repeat-Containing Protein 4 or IAP-Like Protein or X-Linked Inhibitor Of Apoptosis...

    E3 Ubiquitin-Protein Ligase XIAP (Baculoviral IAP Repeat-Containing Protein 4 or IAP-Like Protein or X-Linked Inhibitor Of Apoptosis Protein or XIAP or EC 6.3.2.) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘E3 Ubiquitin-Protein Ligase XIAP (Baculoviral IAP Repeat-Containing Protein 4 or IAP-Like Protein or X-Linked Inhibitor Of Apoptosis Protein or XIAP or EC 6.3.2.) - Pipeline Review, H1 2016’, provides in depth...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0143TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0143TDB
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H1 2016

    Neuropathic Pain - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Neuropathic Pain - Pipeline Review, H1 2016’, provides an overview of the Neuropathic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Neuropathic...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7966IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7966IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H1 2016

    Rheumatoid Arthritis - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2016’, provides an overview of the Rheumatoid Arthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Rheumatoid...

  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7957IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7957IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H1 2016

    Ovarian Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Ovarian Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Ovarian Cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7956IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7956IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H1 2016

    Non-Small Cell Lung Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2016’, provides an overview of the Non-Small Cell Lung Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7954IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7954IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H1 2016

    Pancreatic Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2016’, provides an overview of the Pancreatic Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Pancreatic...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7953IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7953IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H1 2016

    Prostate Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Prostate Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Prostate Cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7952IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7952IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2016

    Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Small-Cell Lung Cancer clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3500CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3500CTIDB
  • View Report: Research and Experts Market Report: Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2016

    Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2016" provides an overview of Anaplastic Large Cell Lymphoma (ALCL) clinical trials scenario. This report provides top line data...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3495CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3495CTIDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2016

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2016" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3491CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3491CTIDB
  • View Report: Research and Experts Market Report: Penile Cancer Global Clinical Trials Review, H1, 2016

    Penile Cancer Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Penile Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Penile Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Penile Cancer....
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3487CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3487CTIDB
  • View Report: Research and Experts Market Report: PharmaPoint: Renal Cell Carcinoma - Global Drug Forecast and Market Analysis to 2023

    PharmaPoint: Renal Cell Carcinoma - Global Drug Forecast and Market Analysis to 2023


    2016-04-21
    Renal cell carcinoma (RCC) is among the 10 most frequently occurring cancers in Western countries. The RCC market is currently dominated by anti-angiogenic agents and tyrosine kinase inhibitors (TKIs) in particular, but it will experience dramatic changes...
  • Market Report
  • Oncology
  • Global
  • $10,995.00
  • Report 05IC-GDHC88PIDR has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC88PIDR
  • View Report: Research and Experts Market Report: Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis

    Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis


    2016-05-01
    GlobalData estimates that the total IO market will be worth approximately $14 billion in 2019, rising to $34 billion by 2024 in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). The main drivers of this growth will come from immune checkpoint...
  • Market Report
  • Oncology
  • Global
  • $10,995.00
  • Report 05IC-GDHC057POA has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC057POA
  • View Report: Research and Experts Market Report: Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) - Pipeline Review, H1 2016

    Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) - Pipeline Review, H1 2016’, provides in depth analysis on Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) targeted...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0269TDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC0269TDB
  • View Report: Research and Experts Market Report: Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) - Pipeline Review, H1 2016

    Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) - Pipeline Review, H1 2016’, provides in depth analysis on Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) targeted...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0247TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0247TDB
  • View Report: Research and Experts Market Report: Gamma Secretase (EC 3.4.23.46) - Pipeline Review, H1 2016

    Gamma Secretase (EC 3.4.23.46) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Gamma Secretase (EC 3.4.23.46) - Pipeline Review, H1 2016’, provides in depth analysis on Gamma Secretase (EC 3.4.23.46) targeted pipeline therapeutics.

    The report provides comprehensive information on the Gamma...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0117TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0117TDB
  • View Report: Research and Experts Market Report: Tyrosine-Protein Kinase BTK (Bruton Agammaglobulinemia Tyrosine Kinase or B-Cell Progenitor Kinase or Agammaglobulinemia Tyrosine...

    Tyrosine-Protein Kinase BTK (Bruton Agammaglobulinemia Tyrosine Kinase or B-Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or EC 2.7.10.2) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Tyrosine-Protein Kinase BTK (Bruton Agammaglobulinemia Tyrosine Kinase or B-Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or EC 2.7.10.2) - Pipeline Review, H1 2016’, provides in depth analysis on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0101TDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC0101TDB
  • View Report: Research and Experts Market Report: C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated...

    C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - Pipeline Review,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0085TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0085TDB
  • View Report: Research and Experts Market Report: CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154...

    CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H1 2016’, provides in depth analysis on CD40 Ligand...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0054TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0054TDB
  • View Report: Research and Experts Market Report: Growth/Differentiation Factor 8 (Myostatin or GDF-8) - Pipeline Review, H1 2016

    Growth/Differentiation Factor 8 (Myostatin or GDF-8) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Growth/Differentiation Factor 8 (Myostatin or GDF-8) - Pipeline Review, H1 2016’, provides in depth analysis on Growth/Differentiation Factor 8 (Myostatin or GDF-8) targeted pipeline therapeutics.

    The report...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0052TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0052TDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016’, provides an overview of the Glioblastoma Multiforme (GBM) pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7963IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7963IDB
  • View Report: Research and Experts Market Report: Gastric and Gastroesophageal Junction Adenocarcinoma - Current and Future Players

    Gastric and Gastroesophageal Junction Adenocarcinoma - Current and Future Players


    2015-12-09
    GlobalData has released its pharma report, “Gastric and Gastroesophageal Junction Adenocarcinoma - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing...
  • Market Report
  • Life Sciences
  • Global
  • $2,995.00
  • Report 05IC-GDHC1047FPR has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC1047FPR
  • View Report: Research and Experts Market Report: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016

    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Hormone Refractory (Castration Resistant, Androgen-Independent)...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3478CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3478CTIDB
  • View Report: Research and Experts Market Report: Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2016

    Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Cutaneous B-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3474CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3474CTIDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016" provides an overview of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3473CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3473CTIDB
  • View Report: Research and Experts Market Report: Brenner Tumor Global Clinical Trials Review, H1, 2016

    Brenner Tumor Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Brenner Tumor Global Clinical Trials Review, H1, 2016" provides an overview of Brenner Tumor clinical trials scenario. This report provides top line data relating to the clinical trials on Brenner Tumor....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3471CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3471CTIDB
  • View Report: Research and Experts Market Report: Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2016

    Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2016" provides an overview of Basal Cell Carcinoma (Basal Cell Epithelioma) clinical trials scenario. This report provides...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3448CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3448CTIDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2016

    Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2016" provides an overview of Hepatocellular Carcinoma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3446CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3446CTIDB
  • View Report: Research and Experts Market Report: Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016

    Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016" provides an overview of Systemic Sclerosis (Scleroderma) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3441CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3441CTIDB
  • View Report: Research and Experts Market Report: Hyperglycemia Global Clinical Trials Review, H1, 2016

    Hyperglycemia Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Hyperglycemia Global Clinical Trials Review, H1, 2016" provides an overview of Hyperglycemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperglycemia....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3435CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3435CTIDB
  • View Report: Research and Experts Market Report: Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H1, 2016

    Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H1, 2016" provides an overview of Idiopathic Pulmonary Fibrosis clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3427CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3427CTIDB
  • View Report: Research and Experts Market Report: Rhabdomyosarcoma Global Clinical Trials Review, H1, 2016

    Rhabdomyosarcoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Rhabdomyosarcoma Global Clinical Trials Review, H1, 2016" provides an overview of Rhabdomyosarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Rhabdomyosarc...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3416CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3416CTIDB
  • View Report: Research and Experts Market Report: Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

    Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Hodgkin...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3414CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3414CTIDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Global Clinical Trials Review, H1, 2016

    Head And Neck Cancer Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Head And Neck Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Head And Neck Cancer clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3413CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3413CTIDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H1, 2016

    Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H1, 2016" provides an overview of Glioblastoma Multiforme (GBM) clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3411CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3411CTIDB
  • View Report: Research and Experts Market Report: Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or...

    Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or CD134 or TNFRSF4) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or CD134 or TNFRSF4) - Pipeline Review, H1 2016’, provides in depth analysis on Tumor...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0056TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0056TDB
  • View Report: Research and Experts Market Report: Tumor Necrosis Factor Receptor Superfamily Member 5 (B-Cell Surface Antigen CD40 or CD40L Receptor or CD40) - Pipeline Review, H1...

    Tumor Necrosis Factor Receptor Superfamily Member 5 (B-Cell Surface Antigen CD40 or CD40L Receptor or CD40) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Tumor Necrosis Factor Receptor Superfamily Member 5 (B-Cell Surface Antigen CD40 or CD40L Receptor or CD40) - Pipeline Review, H1 2016’, provides in depth analysis on Tumor Necrosis Factor Receptor Superfamily...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0055TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0055TDB
  • View Report: Research and Experts Market Report: Wegener Polyangiitis - Pipeline Review, H1 2016

    Wegener Polyangiitis - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Wegener Polyangiitis - Pipeline Review, H1 2016’, provides an overview of the Wegener Polyangiitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Wegener...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8201IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8201IDB
  • View Report: Research and Experts Market Report: Systemic Idiopathic Juvenile Arthritis - Pipeline Review, H1 2016

    Systemic Idiopathic Juvenile Arthritis - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Systemic Idiopathic Juvenile Arthritis - Pipeline Review, H1 2016’, provides an overview of the Systemic Idiopathic Juvenile Arthritis pipeline landscape.

    The report provides comprehensive information on the...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8199IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8199IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016

    Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016’, provides an overview of the Multiple Myeloma (Kahler Disease) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8160IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8160IDB
  • View Report: Research and Experts Market Report: Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016

    Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016’, provides an overview of the Sicca Syndrome (Sjogren) pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8187IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8187IDB
  • View Report: Research and Experts Market Report: Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016

    Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016’, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8167IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8167IDB
  • View Report: Research and Experts Market Report: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016

    Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016’, provides an overview of the Kidney Cancer (Renal Cell Cancer) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8161IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8161IDB
  • View Report: Research and Experts Market Report: Hypertension - Pipeline Review, H1 2016

    Hypertension - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Hypertension - Pipeline Review, H1 2016’, provides an overview of the Hypertension pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hypertension, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7972IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7972IDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H1 2016

    Metastatic Breast Cancer - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Breast Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7968IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7968IDB
  • View Report: Research and Experts Market Report: C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1-Alpha Receptor or CD191 or CCR1) - Pipeline...

    C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1-Alpha Receptor or CD191 or CCR1) - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1-Alpha Receptor or CD191 or CCR1) - Pipeline Review, H1 2016’, provides in depth analysis on C-C Chemokine Receptor Type...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0079TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0079TDB
  • View Report: Research and Experts Market Report: Hypereosinophilic Syndrome - Pipeline Review, H1 2016

    Hypereosinophilic Syndrome - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Hypereosinophilic Syndrome - Pipeline Review, H1 2016’, provides an overview of the Hypereosinophilic Syndrome pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8135IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8135IDB
  • View Report: Research and Experts Market Report: Nephrotic Syndrome - Pipeline Review, H1 2016

    Nephrotic Syndrome - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Nephrotic Syndrome - Pipeline Review, H1 2016’, provides an overview of the Nephrotic Syndrome pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Nephrotic...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8134IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8134IDB
  • View Report: Research and Experts Market Report: Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Pipeline Review, H1 2016

    Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Pipeline Review, H1 2016’, provides an overview of the Vaso-Occlusive Crisis Associated With Sickle Cell Disease pipeline landscape.

    The report provides...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8132IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8132IDB
  • View Report: Research and Experts Market Report: Schizophrenia - Pipeline Review, H1 2016

    Schizophrenia - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Schizophrenia - Pipeline Review, H1 2016’, provides an overview of the Schizophrenia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Schizophrenia,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8107IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8107IDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016’, provides an overview of the Chronic Lymphocytic Leukemia (CLL) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7977IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7977IDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma - Pipeline Review, H1 2016

    Hepatocellular Carcinoma - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Hepatocellular Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Hepatocellular Carcinoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7971IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7971IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Non-Hodgkin Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Non-Hodgkin...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7970IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7970IDB
  • View Report: Research and Experts Market Report: Testicular Cancer Global Clinical Trials Review, H1, 2016

    Testicular Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Testicular Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Testicular Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Testicular...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3408CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3408CTIDB
  • View Report: Research and Experts Market Report: Esophageal Cancer Global Clinical Trials Review, H1, 2016

    Esophageal Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Esophageal Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Esophageal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Esophageal...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3405CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3405CTIDB
  • View Report: Research and Experts Market Report: Uterine Cancer Global Clinical Trials Review, H1, 2016

    Uterine Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Uterine Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Uterine Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Uterine...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3403CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3403CTIDB
  • View Report: Research and Experts Market Report: Gastric Cancer Global Clinical Trials Review, H1, 2016

    Gastric Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Gastric Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Gastric Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Gastric...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3402CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3402CTIDB
  • View Report: Research and Experts Market Report: Cervical Cancer Global Clinical Trials Review, H1, 2016

    Cervical Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Cervical Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Cervical Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Cervical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3401CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3401CTIDB
  • View Report: Research and Experts Market Report: Endometrial Cancer Global Clinical Trials Review, H1, 2016

    Endometrial Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Endometrial Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Endometrial Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3399CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3399CTIDB
  • View Report: Research and Experts Market Report: Laryngeal Cancer Global Clinical Trials Review, H1, 2016

    Laryngeal Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Laryngeal Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Laryngeal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Laryngeal...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3395CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3395CTIDB
  • View Report: Research and Experts Market Report: Vaginal Cancer Global Clinical Trials Review, H1, 2016

    Vaginal Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Vaginal Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Vaginal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Vaginal...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3394CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3394CTIDB
  • View Report: Research and Experts Market Report: Migraine - Pipeline Review, H1 2016

    Migraine - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Migraine - Pipeline Review, H1 2016’, provides an overview of the Migraine pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Migraine, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8006IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8006IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent)...
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8003IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8003IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016

    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016’, provides an overview of the Refractory Acute Myeloid Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8002IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8002IDB
  • View Report: Research and Experts Market Report: Follicular Lymphoma - Pipeline Review, H1 2016

    Follicular Lymphoma - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Follicular Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Follicular Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Follicular...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7999IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7999IDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7997IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7997IDB
  • View Report: Research and Experts Market Report: Cervical Cancer - Pipeline Review, H1 2016

    Cervical Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Cervical Cancer - Pipeline Review, H1 2016’, provides an overview of the Cervical Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Cervical Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7994IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7994IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer - Pipeline Review, H1 2016

    Small-Cell Lung Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Small-Cell Lung Cancer - Pipeline Review, H1 2016’, provides an overview of the Small-Cell Lung Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7991IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7991IDB
  • View Report: Research and Experts Market Report: Metastatic Colorectal Cancer - Pipeline Review, H1 2016

    Metastatic Colorectal Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Metastatic Colorectal Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Colorectal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7985IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7985IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H1 2016

    Myelodysplastic Syndrome - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2016’, provides an overview of the Myelodysplastic Syndrome pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7984IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7984IDB
  • View Report: Research and Experts Market Report: Nuclear Receptor ROR-Gamma (Nuclear Receptor RZR-Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR-Related Orphan Receptor...

    Nuclear Receptor ROR-Gamma (Nuclear Receptor RZR-Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR-Related Orphan Receptor C or Retinoid-Related Orphan Receptor-Gamma or RORC) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Nuclear Receptor ROR-Gamma (Nuclear Receptor RZR-Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR-Related Orphan Receptor C or Retinoid-Related Orphan Receptor-Gamma or RORC) - Pipeline Review, H1 2016’,...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0036TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0036TDB
  • View Report: Research and Experts Market Report: N-Formyl Peptide Receptor 2 (FMLP-Related Receptor I or FMLP-R-I or Formyl Peptide Receptor-Like 1 or HM63 or Lipoxin A4 Receptor...

    N-Formyl Peptide Receptor 2 (FMLP-Related Receptor I or FMLP-R-I or Formyl Peptide Receptor-Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘N-Formyl Peptide Receptor 2 (FMLP-Related Receptor I or FMLP-R-I or Formyl Peptide Receptor-Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Pipeline Review, H1 2016’, provides in depth analysis on N-Formyl...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0033TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0033TDB
  • View Report: Research and Experts Market Report: Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg-2 or LPAR1 or EDG2 or LPA1) - Pipeline Review, H1 2016

    Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg-2 or LPAR1 or EDG2 or LPA1) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg-2 or LPAR1 or EDG2 or LPA1) - Pipeline Review, H1 2016’, provides in depth analysis on Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0029TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0029TDB
  • View Report: Research and Experts Market Report: Systemic Mastocytosis - Pipeline Review, H1 2016

    Systemic Mastocytosis - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Systemic Mastocytosis - Pipeline Review, H1 2016’, provides an overview of the Systemic Mastocytosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8058IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8058IDB
  • View Report: Research and Experts Market Report: Malignant Pleural Mesothelioma - Pipeline Review, H1 2016

    Malignant Pleural Mesothelioma - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Malignant Pleural Mesothelioma - Pipeline Review, H1 2016’, provides an overview of the Malignant Pleural Mesothelioma pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8025IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8025IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2016

    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2016’, provides an overview of the Adenocarcinoma Of The Gastroesophageal Junction pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8024IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8024IDB
  • View Report: Research and Experts Market Report: Thrombocytopenia - Pipeline Review, H1 2016

    Thrombocytopenia - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Thrombocytopenia - Pipeline Review, H1 2016’, provides an overview of the Thrombocytopenia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Thrombocytopenia,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8023IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8023IDB
  • View Report: Research and Experts Market Report: Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016’, provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8019IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8019IDB
  • View Report: Research and Experts Market Report: Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016’, provides an overview of the Relapsed Chronic Lymphocytic Leukemia (CLL) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8017IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8017IDB
  • View Report: Research and Experts Market Report: Endometrial Cancer - Pipeline Review, H1 2016

    Endometrial Cancer - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Endometrial Cancer - Pipeline Review, H1 2016’, provides an overview of the Endometrial Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Endometrial...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8014IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8014IDB
  • View Report: Research and Experts Market Report: Psoriatic Arthritis - Pipeline Review, H1 2016

    Psoriatic Arthritis - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Psoriatic Arthritis - Pipeline Review, H1 2016’, provides an overview of the Psoriatic Arthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Psoriatic...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8010IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8010IDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016

    Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Diffuse Large B-Cell Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7986IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7986IDB
  • View Report: Research and Experts Market Report: Renal Cell Carcinoma - Pipeline Review, H1 2016

    Renal Cell Carcinoma - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Renal Cell Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Renal Cell Carcinoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Renal...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7981IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7981IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H1 2016

    Systemic Lupus Erythematosus - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H1 2016’, provides an overview of the Systemic Lupus Erythematosus pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7998IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7998IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016

    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Head And Neck Cancer Squamous Cell Carcinoma pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7988IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7988IDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7978IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7978IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the B-Cell Non-Hodgkin Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7687IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7687IDB
  • View Report: Research and Experts Market Report: Myelofibrosis Global Clinical Trials Review, H1, 2016

    Myelofibrosis Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Myelofibrosis Global Clinical Trials Review, H1, 2016" provides an overview of Myelofibrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Myelofibrosis....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3385CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3385CTIDB
  • View Report: Research and Experts Market Report: Sickle Cell Disease Global Clinical Trials Review, H1, 2016

    Sickle Cell Disease Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Sickle Cell Disease Global Clinical Trials Review, H1, 2016" provides an overview of Sickle Cell Disease clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3380CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3380CTIDB
  • View Report: Research and Experts Market Report: Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Pipeline Review, H1 2016

    Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Pipeline Review, H1 2016’, provides in depth analysis on Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) targeted pipeline...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0010TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0010TDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H1 2016

    Bladder Cancer - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H1 2016’, provides an overview of the Bladder Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Bladder Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7982IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7982IDB
  • View Report: Research and Experts Market Report: Obesity - Pipeline Review, H1 2016

    Obesity - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Obesity - Pipeline Review, H1 2016’, provides an overview of the Obesity pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Obesity, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7684IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7684IDB
  • View Report: Research and Experts Market Report: Vitiligo - Pipeline Review, H1 2016

    Vitiligo - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Vitiligo - Pipeline Review, H1 2016’, provides an overview of the Vitiligo pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Vitiligo, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7919IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7919IDB
  • View Report: Research and Experts Market Report: Sickle Cell Disease - Pipeline Review, H1 2016

    Sickle Cell Disease - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Sickle Cell Disease - Pipeline Review, H1 2016’, provides an overview of the Sickle Cell Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Sickle...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7824IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7824IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016’, provides an overview of the Relapsed Acute Myeloid Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7820IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7820IDB
  • View Report: Research and Experts Market Report: Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2016

    Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2016’, provides an overview of the Idiopathic Pulmonary Fibrosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7818IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7818IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H1 2016

    Gastric Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H1 2016’, provides an overview of the Gastric Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Gastric Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7815IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7815IDB
  • View Report: Research and Experts Market Report: Head and neck Cancer - Pipeline Review, H1 2016

    Head and neck Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H1 2016’, provides an overview of the Head And Neck Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Head...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7685IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7685IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H1 2016

    Type 2 Diabetes - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2016’, provides an overview of the Type 2 Diabetes pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Type 2 Diabetes,...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7682IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7682IDB
  • View Report: Research and Experts Market Report: Hepatitis B Virus (HBV) Therapeutics - Current and Future Players

    Hepatitis B Virus (HBV) Therapeutics - Current and Future Players


    2016-01-15
    GlobalData has released its pharma report, “Hepatitis B Virus (HBV) Therapeutics - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing HBV Market....
  • Market Report
  • Life Sciences
  • Global
  • $2,995.00
  • Report 05IC-GDHC1045FPR has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC1045FPR
  • View Report: Research and Experts Market Report: Pulmonary Embolism Global Clinical Trials Review, H1, 2016

    Pulmonary Embolism Global Clinical Trials Review, H1, 2016


    2016-04-15
    GlobalData's clinical trial report, “Pulmonary Embolism Global Clinical Trials Review, H1, 2016" provides an overview of Pulmonary Embolism clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3347CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3347CTIDB
  • View Report: Research and Experts Market Report: Congenital Heart Disease Global Clinical Trials Review, H1, 2016

    Congenital Heart Disease Global Clinical Trials Review, H1, 2016


    2016-04-15
    GlobalData's clinical trial report, “Congenital Heart Disease Global Clinical Trials Review, H1, 2016" provides an overview of Congenital Heart Disease clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3345CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3345CTIDB
  • View Report: Research and Experts Market Report: Uveitis - Pipeline Review, H1 2016

    Uveitis - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Uveitis - Pipeline Review, H1 2016’, provides an overview of the Uveitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Uveitis, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7827IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7827IDB
  • View Report: Research and Experts Market Report: Major Depressive Disorder - Pipeline Review, H1 2016

    Major Depressive Disorder - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Major Depressive Disorder - Pipeline Review, H1 2016’, provides an overview of the Major Depressive Disorder pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7826IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7826IDB
  • View Report: Research and Experts Market Report: Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016’, provides an overview of the Recurrent Glioblastoma Multiforme (GBM) pipeline landscape.

    The report provides comprehensive information on the...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7822IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7822IDB
  • View Report: Research and Experts Market Report: Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016

    Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016’, provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7817IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7817IDB
  • View Report: Research and Experts Market Report: Hepatitis C - Pipeline Review, H1 2016

    Hepatitis C - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Hepatitis C - Pipeline Review, H1 2016’, provides an overview of the Hepatitis C pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hepatitis C, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7638IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7638IDB
  • View Report: Research and Experts Market Report: Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2016

    Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2016’, provides an overview of the Deep Vein Thrombosis (DVT) pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7907IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7907IDB
  • View Report: Research and Experts Market Report: Oligodendroglioma - Pipeline Review, H1 2016

    Oligodendroglioma - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Oligodendroglioma - Pipeline Review, H1 2016’, provides an overview of the Oligodendroglioma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Oligodendroglioma,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7861IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7861IDB
  • View Report: Research and Experts Market Report: Lupus Nephritis - Pipeline Review, H1 2016

    Lupus Nephritis - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Lupus Nephritis - Pipeline Review, H1 2016’, provides an overview of the Lupus Nephritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Lupus Nephritis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7856IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7856IDB
  • View Report: Research and Experts Market Report: Pulmonary Fibrosis - Pipeline Review, H1 2016

    Pulmonary Fibrosis - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Pulmonary Fibrosis - Pipeline Review, H1 2016’, provides an overview of the Pulmonary Fibrosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Pulmonary...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7692IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7692IDB
  • View Report: Research and Experts Market Report: Metastatic Melanoma - Pipeline Review, H1 2016

    Metastatic Melanoma - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H1 2016’, provides an overview of the Metastatic Melanoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Metastatic...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7691IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7691IDB
  • View Report: Research and Experts Market Report: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate...
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7689IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7689IDB
  • View Report: Research and Experts Market Report: Psoriasis - Pipeline Review, H1 2016

    Psoriasis - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H1 2016’, provides an overview of the Psoriasis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Psoriasis, complete with...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7686IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7686IDB
  • View Report: Research and Experts Market Report: Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2016

    Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2016’, provides an overview of the Graft Versus Host Disease (GVHD) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7700IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7700IDB
  • View Report: Research and Experts Market Report: Metastatic Pancreatic Cancer - Pipeline Review, H1 2016

    Metastatic Pancreatic Cancer - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Metastatic Pancreatic Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Pancreatic Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7699IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7699IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment - Pipeline Review, H1 2016

    Cognitive Impairment - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H1 2016’, provides an overview of the Cognitive Impairment pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Cognitive...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7696IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7696IDB
  • View Report: Research and Experts Market Report: Depression - Pipeline Review, H1 2016

    Depression - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Depression - Pipeline Review, H1 2016’, provides an overview of the Depression pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Depression, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7581IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7581IDB
  • View Report: Research and Experts Market Report: Arterial Thrombosis - Pipeline Review, H1 2016

    Arterial Thrombosis - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Arterial Thrombosis - Pipeline Review, H1 2016’, provides an overview of the Arterial Thrombosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Arterial...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7739IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7739IDB
  • View Report: Research and Experts Market Report: Liver Fibrosis - Pipeline Review, H1 2016

    Liver Fibrosis - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Liver Fibrosis - Pipeline Review, H1 2016’, provides an overview of the Liver Fibrosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Liver Fibrosis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7709IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7709IDB
  • View Report: Research and Experts Market Report: Pulmonary Arterial Hypertension - Pipeline Review, H1 2016

    Pulmonary Arterial Hypertension - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Pulmonary Arterial Hypertension - Pipeline Review, H1 2016’, provides an overview of the Pulmonary Arterial Hypertension pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7707IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7707IDB
  • View Report: Research and Experts Market Report: Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016

    Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016" provides an overview of Systemic Sclerosis (Scleroderma) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3327CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3327CTIDB
  • View Report: Research and Experts Market Report: Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H1, 2016

    Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H1, 2016" provides an overview of Deep Vein Thrombosis (DVT) clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3326CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3326CTIDB
  • View Report: Research and Experts Market Report: Thrombophilia Global Clinical Trials Review, H1, 2016

    Thrombophilia Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Thrombophilia Global Clinical Trials Review, H1, 2016" provides an overview of Thrombophilia clinical trials scenario. This report provides top line data relating to the clinical trials on Thrombophilia....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3325CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3325CTIDB
  • View Report: Research and Experts Market Report: Sicca Syndrome (Sjogren) Global Clinical Trials Review, H1, 2016

    Sicca Syndrome (Sjogren) Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Sicca Syndrome (Sjogren) Global Clinical Trials Review, H1, 2016" provides an overview of Sicca Syndrome (Sjogren) clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3319CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3319CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Head and Neck Squamous Cell Carcinoma - Opportunity Analysis and Forecast to 2024

    OpportunityAnalyzer: Head and Neck Squamous Cell Carcinoma - Opportunity Analysis and Forecast to 2024


    2016-02-02
    The head and neck cancer (HNC) market is one currently dominated by generic chemotherapies, with little competition from branded therapies. The market landscape is set to undergo substantial growth between 2014 and 2024. The main drivers of growth will...
  • Market Report
  • Life Sciences
  • Global
  • $10,995.00
  • Report 05IC-GDHC054POA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC054POA
  • View Report: Research and Experts Market Report: Vitiligo Global Clinical Trials Review, H1, 2016

    Vitiligo Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Vitiligo Global Clinical Trials Review, H1, 2016" provides an overview of Vitiligo clinical trials scenario. This report provides top line data relating to the clinical trials on Vitiligo. Report includes...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3314CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3314CTIDB
  • View Report: Research and Experts Market Report: Lupus Nephritis Global Clinical Trials Review, H1, 2016

    Lupus Nephritis Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Lupus Nephritis Global Clinical Trials Review, H1, 2016" provides an overview of Lupus Nephritis clinical trials scenario. This report provides top line data relating to the clinical trials on Lupus...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3304CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3304CTIDB
  • View Report: Research and Experts Industry Report: Bristol-Myers Squibb Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

    Bristol-Myers Squibb Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report


    2016-06-30
    Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive...
  • Industry Report
  • Life Sciences
  • United States
  • $350.00
  • Report 05IK-A5CFFC27-0CAE-4076-895F-80 has a star rating of 4.4 out of 5
  • Go to More information on Report 05IK-A5CFFC27-0CAE-4076-895F-80
  • View Report: Research and Experts Market Report: Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2016

    Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2016’, provides an overview of the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) pipeline landscape....
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7732IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7732IDB
  • View Report: Research and Experts Market Report: Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2016

    Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2016’, provides an overview of the Congestive Heart Failure (Heart Failure) pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7552IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7552IDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Hodgkin

    OpportunityAnalyzer: Hodgkin's Lymphoma (HL) - Opportunity Analysis and Forecasts to 2024


    2016-01-01
    Hodgkin’s lymphoma (HL), or Hodgkin’s disease, is a malignancy which involves the lymph nodes and the lymphatic system. HL is a relatively rare type of cancer, accounting for 12% of all lymphomas and 0.6% of all new cancer cases, but overall...
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC052POA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC052POA
  • View Report: Research and Experts Market Report: Pulmonary Embolism - Pipeline Review, H1 2016

    Pulmonary Embolism - Pipeline Review, H1 2016


    2016-03-16
    Global Markets Direct’s, ‘Pulmonary Embolism - Pipeline Review, H1 2016’, provides an overview of the Pulmonary Embolism pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Pulmonary...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7800IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7800IDB
  • View Report: Research and Experts Market Report: Polycythemia Vera - Pipeline Review, H1 2016

    Polycythemia Vera - Pipeline Review, H1 2016


    2016-03-16
    Global Markets Direct’s, ‘Polycythemia Vera - Pipeline Review, H1 2016’, provides an overview of the Polycythemia Vera pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Polycythemia...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7756IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7756IDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H1 2016


    2016-03-16
    Global Markets Direct’s, ‘Alzheimer’s Disease - Pipeline Review, H1 2016’, provides an overview of the Alzheimer’s Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7570IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7570IDB
  • View Report: Research and Experts Market Report: PharmaPoint: Hepatitis B Virus (HBV) Therapeutics - Global Drug Forecast and Market Analysis to 2024

    PharmaPoint: Hepatitis B Virus (HBV) Therapeutics - Global Drug Forecast and Market Analysis to 2024


    2016-01-01
    Chronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the availability of effective prophylactic vaccines, the disease remains a serious global health...
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC117PIDR has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC117PIDR
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Glioblastoma - Opportunity Analysis and Forecasts to 2024

    OpportunityAnalyzer: Glioblastoma - Opportunity Analysis and Forecasts to 2024


    2015-12-22
    Glioblastoma multiforme (GBM) is characterized as a disease with some of the highest unmet needs in oncology, with patients having a median overall survival (OS) of between one and two years. The lack of therapies is primarily due to the inability of...
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC053POA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC053POA
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: B-Cell Non-Hodgkin

    OpportunityAnalyzer: B-Cell Non-Hodgkin's Lymphoma (NHL) - Opportunity Analysis and Forecasts to 2024


    2016-01-01
    Non-Hodgkin’s lymphoma (NHL) comprises a heterogeneous group of lymphoproliferative malignancies that arise in the B cells, T cells, or natural killer (NK) cells within the lymphoid tissue, such as the lymph nodes, bone marrow, thymus, and spleen....
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC018POA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC018POA
  • View Report: Research and Experts Company Report: F. Hoffmann-La Roche Ltd. (ROG) - Medical Equipment - Deals and Alliances Profile

    F. Hoffmann-La Roche Ltd. (ROG) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    F. Hoffmann-La Roche Ltd. (Roche) is a research-focused healthcare company. It is one of the leading providers of biopharmaceuticals, cancer medicines and in vitro diagnostics (IVD) systems. Its major products include medicines to treat cancers, brain...
  • Company Report
  • Medical Devices
  • Switzerland
  • $250.00
  • Report 05IB-GDME756D has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GDME756D
  • View Report: Research and Experts Company Report: Merck & Co., Inc. (MRK) - Medical Equipment - Deals and Alliances Profile

    Merck & Co., Inc. (MRK) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Merck & Co., Inc. (Merck) is a healthcare company, which focuses on the discovery, development, manufacture and commercialization of branded pharmaceuticals, biologic therapies, prescription and over-the-counter (OTC) medicines, vaccines, consumer...
  • Company Report
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME6319D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME6319D
  • View Report: Research and Experts Company Report: Genentech, Inc. - Medical Equipment - Deals and Alliances Profile

    Genentech, Inc. - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Genentech, Inc. (Genentech) is a biotech company that undertakes discovery, development, manufacture and commercialization of medicines for the treatment of patients with serious medical conditions. The company focuses on developing drugs for unmet medica...
  • Company Report
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME4341D has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GDME4341D
  • View Report: Research and Experts Company Report: AbbVie Inc. (ABBV) - Medical Equipment - Deals and Alliances Profile

    AbbVie Inc. (ABBV) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company that carries out the research, development, manufacture and commercialization of advanced therapies to treat complex and serious diseases. The company’s products are used to treat...
  • Company Report
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME430057D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME430057D
  • View Report: Research and Experts Company Report: GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile

    GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    GlaxoSmithKline plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of respiratory, cardiovascular, metabol...
  • Company Report
  • Medical Devices
  • United Kingdom
  • $250.00
  • Report 05IB-GDME4279D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME4279D
  • View Report: Research and Experts Company Report: Sanofi (SAN) - Medical Equipment - Deals and Alliances Profile

    Sanofi (SAN) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Sanofi is a healthcare company, which focuses on the research, development, manufacture and marketing of therapeutic solutions.The company offers a wide range of medicines, vaccines and innovative therapeutic solutions. Its product portfolio includes...
  • Company Report
  • Medical Devices
  • France
  • $250.00
  • Report 05IB-GDME3811D has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GDME3811D
  • View Report: Research and Experts Company Report: Amgen Inc. (AMGN) - Medical Equipment - Deals and Alliances Profile

    Amgen Inc. (AMGN) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Amgen Inc. (Amgen) is a biotechnology company. It undertakes the discovery, development, manufacture and commercialization of innovative human therapeutics. The company pioneered the development of new products based on advances in recombinant DNA and...
  • Company Report
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME3778D has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GDME3778D
  • View Report: Research and Experts Company Report: Teva Pharmaceutical Industries Limited (TEVA) - Medical Equipment - Deals and Alliances Profile

    Teva Pharmaceutical Industries Limited (TEVA) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Teva Pharmaceutical Industries Ltd. ( (Teva) is a pharmaceutical company, which focuses on the development, manufacture and marketing of generics, branded pharmaceuticals and active pharmaceutical ingredients (APIs). It offers chemical and therapeutic...
  • Company Report
  • Medical Devices
  • Israel
  • $250.00
  • Report 05IB-GDME33504D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME33504D
  • View Report: Research and Experts Company Report: Pfizer Inc. (PFE) - Medical Equipment - Deals and Alliances Profile

    Pfizer Inc. (PFE) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Pfizer Inc. (Pfizer) is a biopharmaceutical company, which focuses on the discovery, development, manufacture and marketing of healthcare products such as medicines, vaccines and consumer health care products. It offers products for the treatment of respi...
  • Company Report
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME32190D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME32190D
  • View Report: Research and Experts Company Report: Mylan N.V. (MYL) - Medical Equipment - Deals and Alliances Profile

    Mylan N.V. (MYL) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Mylan N.V., formerly, Mylan Inc. is one of the leading generic drug and specialty drug manufacturing companies in the world. The company focuses on the development, licensing, production, commercialization and distribution of generics, branded generics,...
  • Company Report
  • Medical Devices
  • United Kingdom
  • $250.00
  • Report 05IB-GDME31565D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME31565D
  • View Report: Research and Experts Company Report: Novartis AG (NOVN) - Medical Equipment - Deals and Alliances Profile

    Novartis AG (NOVN) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Novartis AG (Novartis) is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic products for the treatment of diseases and disorders in humans and animals. It provides drugs for the treatmen...
  • Company Report
  • Medical Devices
  • Switzerland
  • $250.00
  • Report 05IB-GDME24864D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME24864D
  • View Report: Research and Experts Company Report: Pfizer Inc. (PFE) - Financial and Strategic SWOT Analysis Review

    Pfizer Inc. (PFE) - Financial and Strategic SWOT Analysis Review


    2016-03-01
    Pfizer Inc. (Pfizer) is a biopharmaceutical company, which focuses on the discovery, development, manufacture and marketing of healthcare products such as medicines, vaccines and consumer health care products. It offers products for the treatment of respi...
  • Company Report
  • Iron and steel Construction
  • United States
  • $125.00
  • Report 05IB-GDPH32190FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GDPH32190FSA
  • View Report: Research and Experts Company Report: Novartis AG (NOVN) - Financial and Strategic SWOT Analysis Review

    Novartis AG (NOVN) - Financial and Strategic SWOT Analysis Review


    2016-03-01
    Novartis AG (Novartis) is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic products for the treatment of diseases and disorders in humans and animals. It provides drugs for the treatmen...
  • Company Report
  • Iron and steel Construction
  • Switzerland
  • $125.00
  • Report 05IB-GDPH24864FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GDPH24864FSA
  • View Report: Research and Experts Company Report: Teva Pharmaceutical Industries Limited (TEVA) - Financial and Strategic SWOT Analysis Review

    Teva Pharmaceutical Industries Limited (TEVA) - Financial and Strategic SWOT Analysis Review


    2016-02-23
    Teva Pharmaceutical Industries Ltd. ( (Teva) is a pharmaceutical company, which focuses on the development, manufacture and marketing of generics, branded pharmaceuticals and active pharmaceutical ingredients (APIs). It offers chemical and therapeutic...
  • Company Report
  • Iron and steel Construction
  • Israel
  • $125.00
  • Report 05IB-GDPH33504FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GDPH33504FSA
  • View Report: Research and Experts Market Report: Indolent Lymphoma - Pipeline Review, H1 2016

    Indolent Lymphoma - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Indolent Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Indolent...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7663IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7663IDB
  • View Report: Research and Experts Market Report: Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2016

    Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2016’, provides an overview of the Systemic Sclerosis (Scleroderma) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7619IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7619IDB
  • View Report: Research and Experts Market Report: Duchenne Muscular Dystrophy - Pipeline Review, H1 2016

    Duchenne Muscular Dystrophy - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Duchenne Muscular Dystrophy - Pipeline Review, H1 2016’, provides an overview of the Duchenne Muscular Dystrophy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7604IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7604IDB
  • View Report: Research and Experts Market Report: Colitis - Pipeline Review, H1 2016

    Colitis - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Colitis - Pipeline Review, H1 2016’, provides an overview of the Colitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Colitis, complete with analysis...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7593IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7593IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2016

    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2016’, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS) pipeline landscape.

    The report provides...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7562IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7562IDB
  • View Report: Research and Experts Market Report: Atrial Fibrillation - Pipeline Review, H1 2016

    Atrial Fibrillation - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Atrial Fibrillation - Pipeline Review, H1 2016’, provides an overview of the Atrial Fibrillation pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Atrial...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7550IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7550IDB
  • View Report: Research and Experts Market Report: Alopecia - Pipeline Review, H1 2016

    Alopecia - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Alopecia - Pipeline Review, H1 2016’, provides an overview of the Alopecia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Alopecia, complete with analysis...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7585IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7585IDB
  • View Report: Research and Experts Market Report: Sepsis - Pipeline Review, H1 2016

    Sepsis - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Sepsis - Pipeline Review, H1 2016’, provides an overview of the Sepsis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Sepsis, complete with analysis...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7672IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7672IDB
  • View Report: Research and Experts Market Report: Venous Thromboembolism Global Clinical Trials Review, H1, 2016

    Venous Thromboembolism Global Clinical Trials Review, H1, 2016


    2016-02-25
    GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H1, 2016" provides an overview of Venous Thromboembolism clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3233CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3233CTIDB
  • View Report: Research and Experts Market Report: Thromboembolism Global Clinical Trials Review, H1, 2016

    Thromboembolism Global Clinical Trials Review, H1, 2016


    2016-02-25
    GlobalData's clinical trial report, “Thromboembolism Global Clinical Trials Review, H1, 2016" provides an overview of Thromboembolism clinical trials scenario. This report provides top line data relating to the clinical trials on Thromboembolism...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3232CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3232CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Sjögren

    OpportunityAnalyzer: Sjögren's Syndrome - Opportunity Analysis and Forecast to 2024


    2015-12-19
    Sjögren’s syndrome (SS) is a slow progressing chronic autoimmune disease, which predominantly affects middle-aged women, and is characterized by lymphocytic infiltration of the exocrine glands, mainly the lacrimal and salivary glands, resulting...
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC048POA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC048POA
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Bladder Cancer - Opportunity Analysis and Forecasts to 2017

    OpportunityAnalyzer: Bladder Cancer - Opportunity Analysis and Forecasts to 2017


    2015-12-19
    The bladder cancer market has remained largely unchanged in the past 10-20 years. However, significant expansion is expected starting in 2016, with the introduction of several new therapies that are projected to fuel market growth. In addition, bladder...
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC015EPOA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC015EPOA
  • View Report: Research and Experts Market Report: Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H1, 2016

    Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H1, 2016" provides an overview of Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) clinical trials scenario....
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3224CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3224CTIDB
  • View Report: Research and Experts Market Report: Atrial Flutter Global Clinical Trials Review, H1, 2016

    Atrial Flutter Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Atrial Flutter Global Clinical Trials Review, H1, 2016" provides an overview of Atrial Flutter clinical trials scenario. This report provides top line data relating to the clinical trials on Atrial Flutter....
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3218CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3218CTIDB
  • View Report: Research and Experts Market Report: Thromboembolic Disease Global Clinical Trials Review, H1, 2016

    Thromboembolic Disease Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Thromboembolic Disease Global Clinical Trials Review, H1, 2016" provides an overview of Thromboembolic Disease clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3217CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3217CTIDB
  • View Report: Research and Experts Market Report: Joint Pain Global Clinical Trials Review, H1, 2016

    Joint Pain Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Joint Pain Global Clinical Trials Review, H1, 2016" provides an overview of Joint Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Joint Pain. Report...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3216CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3216CTIDB
  • View Report: Research and Experts Market Report: Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2016

    Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2016" provides an overview of Neuroendocrine Carcinoma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3215CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3215CTIDB
  • View Report: Research and Experts Market Report: PharmaPoint: Gastric and Gastroesophageal Junction Adenocarcinoma - Global Drug Forecast and Market Analysis to 2024

    PharmaPoint: Gastric and Gastroesophageal Junction Adenocarcinoma - Global Drug Forecast and Market Analysis to 2024


    2015-12-09
    Gastric and gastroesophageal junction adenocarcinoma (G/GEJAC) represents the majority of gastric cancer cases worldwide. It is the fifth most diagnosed cancer globally, and the third most common cause of cancer death in the world. The major treatments...
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC123PIDR has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC123PIDR
  • View Report: Research and Experts Market Report: Melanoma Global Clinical Trials Review, H1, 2016

    Melanoma Global Clinical Trials Review, H1, 2016


    2016-01-31
    GlobalData's clinical trial report, “Melanoma Global Clinical Trials Review, H1, 2016" provides an overview of Melanoma clinical trials scenario. This report provides top line data relating to the clinical trials on Melanoma. Report includes...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3214CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3214CTIDB
  • View Report: Research and Experts Market Report: Cachexia Global Clinical Trials Review, H1, 2016

    Cachexia Global Clinical Trials Review, H1, 2016


    2016-01-31
    GlobalData's clinical trial report, “Cachexia Global Clinical Trials Review, H1, 2016" provides an overview of Cachexia clinical trials scenario. This report provides top line data relating to the clinical trials on Cachexia. Report includes...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3213CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3213CTIDB
  • View Report: Research and Experts Market Report: Hemostasis Global Clinical Trials Review, H1, 2016

    Hemostasis Global Clinical Trials Review, H1, 2016


    2016-01-31
    GlobalData's clinical trial report, “Hemostasis Global Clinical Trials Review, H1, 2016" provides an overview of Hemostasis clinical trials scenario. This report provides top line data relating to the clinical trials on Hemostasis. Report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3209CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3209CTIDB
  • View Report: Research and Experts Market Report: Liver Fibrosis Global Clinical Trials Review, H1, 2016

    Liver Fibrosis Global Clinical Trials Review, H1, 2016


    2016-01-31
    GlobalData's clinical trial report, “Liver Fibrosis Global Clinical Trials Review, H1, 2016" provides an overview of Liver Fibrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Liver Fibrosis....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3204CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3204CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Acute Myeloid Leukemia (AML) - Opportunity Analysis and Forecasts to 2024

    OpportunityAnalyzer: Acute Myeloid Leukemia (AML) - Opportunity Analysis and Forecasts to 2024


    2015-12-01
    Acute myeloid (myelogenous, myelocytic) leukemia (AML) is a rapidly progressing blood cancer with an extremely poor overall prognosis. AML predominantly affects the elderly population and this subgroup of patients has an exceptionally high level of unmet...
  • Market Report
  • Life Sciences
  • Global
  • $10,995.00
  • Report 05IC-GDHC051POA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC051POA
  • View Report: Research and Experts Company Report: Intercept Pharmaceuticals Inc (ICPT) - Financial and Strategic SWOT Analysis Review

    Intercept Pharmaceuticals Inc (ICPT) - Financial and Strategic SWOT Analysis Review


    2016-11-22
    Intercept Pharmaceuticals Inc (Intercept) is a biopharmaceutical company that researches, develops and commercializes treatments for chronic liver and intestinal diseases. It develops products using its proprietary bile acid chemistry. The company’s...
  • Company Report
  • Life Sciences
  • United States
  • $300.00
  • Report 05IC-GDPH138103FSA has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDPH138103FSA
  • View Report: Research and Experts Market Report: PharmaPoint: Multiple Myeloma - Global Drug Forecast and Market Analysis to 2023

    PharmaPoint: Multiple Myeloma - Global Drug Forecast and Market Analysis to 2023


    2015-11-01
    The Multiple Myeloma (MM) market is currently dominated by Velcade and Revlimid, and the market is set to undergo substantial growth between 2013 and 2023. The main drivers of growth will be the launch of monoclonal antibodies (mAbs) Empliciti and daratum...
  • Market Report
  • Healthcare
  • Global
  • $10,995.00
  • Report 05IC-GDHC114PIDR has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC114PIDR
  • View Report: Research and Experts Market Report: Mycobacterium avium-Intracellulare Infections Global Clinical Trials Review, H2, 2015

    Mycobacterium avium-Intracellulare Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Mycobacterium avium-Intracellulare Infections Global Clinical Trials Review, H2, 2015" provides an overview of Mycobacterium avium-Intracellulare Infections clinical trials scenario. This report provides...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3184CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3184CTIDB
  • View Report: Research and Experts Market Report: Complicated Skin And Skin Structure Infections (cSSSI) Global Clinical Trials Review, H2, 2015

    Complicated Skin And Skin Structure Infections (cSSSI) Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Complicated Skin And Skin Structure Infections (cSSSI) Global Clinical Trials Review, H2, 2015" provides an overview of Complicated Skin And Skin Structure Infections (cSSSI) clinical trials scenario....
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3183CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3183CTIDB
  • View Report: Research and Experts Market Report: Chlamydia trachomatis Infections Global Clinical Trials Review, H2, 2015

    Chlamydia trachomatis Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Chlamydia trachomatis Infections Global Clinical Trials Review, H2, 2015" provides an overview of Chlamydia trachomatis Infections clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3182CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3182CTIDB
  • View Report: Research and Experts Market Report: Skin And Skin Structure Infections (SSSI) Caused By Bacteria Global Clinical Trials Review, H2, 2015

    Skin And Skin Structure Infections (SSSI) Caused By Bacteria Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Skin And Skin Structure Infections (SSSI) Caused By Bacteria Global Clinical Trials Review, H2, 2015" provides an overview of Skin And Skin Structure Infections (SSSI) Caused By Bacteria clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3181CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3181CTIDB
  • View Report: Research and Experts Market Report: Staphylococcus aureus Infections Global Clinical Trials Review, H2, 2015

    Staphylococcus aureus Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Staphylococcus aureus Infections Global Clinical Trials Review, H2, 2015" provides an overview of Staphylococcus aureus Infections clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3180CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3180CTIDB
  • View Report: Research and Experts Market Report: Streptococcal Infections Global Clinical Trials Review, H2, 2015

    Streptococcal Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Streptococcal Infections Global Clinical Trials Review, H2, 2015" provides an overview of Streptococcal Infections clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3179CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3179CTIDB
  • View Report: Research and Experts Market Report: Haemophilus influenzae Infections Global Clinical Trials Review, H2, 2015

    Haemophilus influenzae Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Haemophilus influenzae Infections Global Clinical Trials Review, H2, 2015" provides an overview of Haemophilus influenzae Infections clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3178CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3178CTIDB
  • View Report: Research and Experts Market Report: Pseudomonas aeruginosa Infections Global Clinical Trials Review, H2, 2015

    Pseudomonas aeruginosa Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Pseudomonas aeruginosa Infections Global Clinical Trials Review, H2, 2015" provides an overview of Pseudomonas aeruginosa Infections clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3177CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3177CTIDB
  • View Report: Research and Experts Market Report: Haemophilus influenzae Type B Infections Global Clinical Trials Review, H2, 2015

    Haemophilus influenzae Type B Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Haemophilus influenzae Type B Infections Global Clinical Trials Review, H2, 2015" provides an overview of Haemophilus influenzae Type B Infections clinical trials scenario. This report provides top line...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3176CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3176CTIDB
  • View Report: Research and Experts Market Report: Rotavirus Infections Global Clinical Trials Review, H2, 2015

    Rotavirus Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Rotavirus Infections Global Clinical Trials Review, H2, 2015" provides an overview of Rotavirus Infections clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3175CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3175CTIDB
  • View Report: Research and Experts Market Report: Influenza B Infections Global Clinical Trials Review, H2, 2015

    Influenza B Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Influenza B Infections Global Clinical Trials Review, H2, 2015" provides an overview of Influenza B Infections clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3174CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3174CTIDB
  • View Report: Research and Experts Market Report: Pandemic Influenza Global Clinical Trials Review, H2, 2015

    Pandemic Influenza Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Pandemic Influenza Global Clinical Trials Review, H2, 2015" provides an overview of Pandemic Influenza clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3173CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3173CTIDB
  • View Report: Research and Experts Market Report: Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015

    Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015" provides an overview of Pelvic Inflammatory Disease (Pelvic Infections) clinical trials scenario. This report...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3172CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3172CTIDB
  • View Report: Research and Experts Market Report: Neisseria meningitidis Infections Global Clinical Trials Review, H2, 2015

    Neisseria meningitidis Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Neisseria meningitidis Infections Global Clinical Trials Review, H2, 2015" provides an overview of Neisseria meningitidis Infections clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3171CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3171CTIDB
  • View Report: Research and Experts Market Report: Influenza A Infections Global Clinical Trials Review, H2, 2015

    Influenza A Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Influenza A Infections Global Clinical Trials Review, H2, 2015" provides an overview of Influenza A Infections clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3170CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3170CTIDB
  • View Report: Research and Experts Market Report: Chronic Bacterial Prostatitis Global Clinical Trials Review, H2, 2015

    Chronic Bacterial Prostatitis Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Chronic Bacterial Prostatitis Global Clinical Trials Review, H2, 2015" provides an overview of Chronic Bacterial Prostatitis clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3169CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3169CTIDB
  • View Report: Research and Experts Market Report: Epstein-Barr Viral Infections Global Clinical Trials Review, H2, 2015

    Epstein-Barr Viral Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Epstein-Barr Viral Infections Global Clinical Trials Review, H2, 2015" provides an overview of Epstein-Barr Viral Infections clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3168CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3168CTIDB
  • View Report: Research and Experts Market Report: Clostridium Infections Global Clinical Trials Review, H2, 2015

    Clostridium Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Clostridium Infections Global Clinical Trials Review, H2, 2015" provides an overview of Clostridium Infections clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3167CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3167CTIDB
  • View Report: Research and Experts Market Report: Hepatitis Global Clinical Trials Review, H2, 2015

    Hepatitis Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Hepatitis Global Clinical Trials Review, H2, 2015" provides an overview of Hepatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis. Report...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3166CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3166CTIDB
  • View Report: Research and Experts Market Report: Seasonal Influenza Global Clinical Trials Review, H2, 2015

    Seasonal Influenza Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Seasonal Influenza Global Clinical Trials Review, H2, 2015" provides an overview of Seasonal Influenza clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3165CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3165CTIDB
  • View Report: Research and Experts Market Report: Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2015

    Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2015" provides an overview of Hand, Foot And Mouth Disease clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3164CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3164CTIDB
  • View Report: Research and Experts Market Report: Hemophagocytic Lymphohistiocytosis Global Clinical Trials Review, H2, 2015

    Hemophagocytic Lymphohistiocytosis Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Hemophagocytic Lymphohistiocytosis Global Clinical Trials Review, H2, 2015" provides an overview of Hemophagocytic Lymphohistiocytosis clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3163CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3163CTIDB
  • View Report: Research and Experts Market Report: Osteoarthritis Global Clinical Trials Review, H2, 2015

    Osteoarthritis Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Osteoarthritis Global Clinical Trials Review, H2, 2015" provides an overview of Osteoarthritis clinical trials scenario. This report provides top line data relating to the clinical trials on Osteoarthritis....
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3162CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3162CTIDB
  • View Report: Research and Experts Market Report: Measles Global Clinical Trials Review, H2, 2015

    Measles Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Measles Global Clinical Trials Review, H2, 2015" provides an overview of Measles clinical trials scenario. This report provides top line data relating to the clinical trials on Measles. Report includes...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3161CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3161CTIDB
  • View Report: Research and Experts Market Report: Brucellosis Global Clinical Trials Review, H2, 2015

    Brucellosis Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Brucellosis Global Clinical Trials Review, H2, 2015" provides an overview of Brucellosis clinical trials scenario. This report provides top line data relating to the clinical trials on Brucellosis. Report...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3160CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3160CTIDB
  • View Report: Research and Experts Market Report: Vaginitis Global Clinical Trials Review, H2, 2015

    Vaginitis Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Vaginitis Global Clinical Trials Review, H2, 2015" provides an overview of Vaginitis clinical trials scenario. This report provides top line data relating to the clinical trials on Vaginitis. Report...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3159CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3159CTIDB
  • View Report: Research and Experts Market Report: Mumps Global Clinical Trials Review, H2, 2015

    Mumps Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Mumps Global Clinical Trials Review, H2, 2015" provides an overview of Mumps clinical trials scenario. This report provides top line data relating to the clinical trials on Mumps. Report includes an...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3158CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3158CTIDB
  • View Report: Research and Experts Market Report: Rubella Global Clinical Trials Review, H2, 2015

    Rubella Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Rubella Global Clinical Trials Review, H2, 2015" provides an overview of Rubella clinical trials scenario. This report provides top line data relating to the clinical trials on Rubella. Report includes...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3157CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3157CTIDB
  • View Report: Research and Experts Market Report: Corneal Graft Rejection Global Clinical Trials Review, H2, 2015

    Corneal Graft Rejection Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Corneal Graft Rejection Global Clinical Trials Review, H2, 2015" provides an overview of Corneal Graft Rejection clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3156CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3156CTIDB
  • View Report: Research and Experts Market Report: Drug Hypersensitivity Reactions Global Clinical Trials Review, H2, 2015

    Drug Hypersensitivity Reactions Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Drug Hypersensitivity Reactions Global Clinical Trials Review, H2, 2015" provides an overview of Drug Hypersensitivity Reactions clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3155CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3155CTIDB
  • View Report: Research and Experts Market Report: Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Global Clinical Trials Review, H2, 2015

    Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Global Clinical Trials Review, H2, 2015" provides an overview of Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3154CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3154CTIDB
  • View Report: Research and Experts Market Report: Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2015

    Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2015" provides an overview of Hematopoietic Stem Cell Transplantation clinical trials scenario. This report provides top line...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3153CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3153CTIDB
  • View Report: Research and Experts Market Report: Allergies Global Clinical Trials Review, H2, 2015

    Allergies Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Allergies Global Clinical Trials Review, H2, 2015" provides an overview of Allergies clinical trials scenario. This report provides top line data relating to the clinical trials on Allergies. Report...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3152CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3152CTIDB
  • View Report: Research and Experts Market Report: Chronic Inflammation Global Clinical Trials Review, H2, 2015

    Chronic Inflammation Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Chronic Inflammation Global Clinical Trials Review, H2, 2015" provides an overview of Chronic Inflammation clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3151CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3151CTIDB
  • View Report: Research and Experts Market Report: Myelofibrosis Global Clinical Trials Review, H2, 2015

    Myelofibrosis Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Myelofibrosis Global Clinical Trials Review, H2, 2015" provides an overview of Myelofibrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Myelofibrosis....
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3150CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3150CTIDB
  • View Report: Research and Experts Market Report: Lupus Nephritis - Pipeline Review, H2 2015

    Lupus Nephritis - Pipeline Review, H2 2015


    2015-10-30
    Lupus Nephritis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Lupus Nephritis - Pipeline Review, H2 2015’, provides an overview of the Lupus Nephritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7244IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7244IDB
  • View Report: Research and Experts Market Report: Major Depressive Disorder - Pipeline Review, H2 2015

    Major Depressive Disorder - Pipeline Review, H2 2015


    2015-10-30
    Major Depressive Disorder - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Major Depressive Disorder - Pipeline Review, H2 2015’, provides an overview of the Major Depressive Disorder’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7217IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7217IDB
  • View Report: Research and Experts Market Report: Malignant Pleural Mesothelioma - Pipeline Review, H2 2015

    Malignant Pleural Mesothelioma - Pipeline Review, H2 2015


    2015-10-30
    Malignant Pleural Mesothelioma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Malignant Pleural Mesothelioma - Pipeline Review, H2 2015’, provides an overview of the Malignant Pleural Mesothelioma’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7231IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7231IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma of the Gastroesophageal Junction - Pipeline Review, H2 2015

    Adenocarcinoma of the Gastroesophageal Junction - Pipeline Review, H2 2015


    2015-10-30
    Adenocarcinoma of the Gastroesophageal Junction - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2015’, provides an overview of the Adenocarcinoma Of The...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7228IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7228IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015


    2015-10-30
    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015’, provides an overview of the Refractory Acute Myeloid Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7212IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7212IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015


    2015-10-30
    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7211IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7211IDB
  • View Report: Research and Experts Market Report: Mantle Cell Lymphoma - Pipeline Review, H2 2015

    Mantle Cell Lymphoma - Pipeline Review, H2 2015


    2015-10-21
    Mantle Cell Lymphoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6961IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC6961IDB
  • View Report: Research and Experts Market Report: Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2015

    Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2015


    2015-10-21
    Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2015’, provides an overview of the Non-Alcoholic Steatohepatitis’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6840IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC6840IDB
  • View Report: Research and Experts Market Report: Brain Cancer - Pipeline Review, H2 2015

    Brain Cancer - Pipeline Review, H2 2015


    2015-10-21
    Brain Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Brain Cancer - Pipeline Review, H2 2015’, provides an overview of the Brain Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6838IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC6838IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2015

    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2015


    2015-10-14
    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2015’, provides an overview of the...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6856IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6856IDB
  • View Report: Research and Experts Market Report: Atrial Fibrillation - Pipeline Review, H2 2015

    Atrial Fibrillation - Pipeline Review, H2 2015


    2015-10-14
    Atrial Fibrillation - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Atrial Fibrillation - Pipeline Review, H2 2015’, provides an overview of the Atrial Fibrillation’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6854IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6854IDB
  • View Report: Research and Experts Market Report: Refractory Multiple Myeloma - Pipeline Review, H2 2015

    Refractory Multiple Myeloma - Pipeline Review, H2 2015


    2015-09-30
    Refractory Multiple Myeloma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Refractory Multiple Myeloma - Pipeline Review, H2 2015’, provides an overview of the Refractory Multiple Myeloma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7074IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7074IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment - Pipeline Review, H2 2015

    Cognitive Impairment - Pipeline Review, H2 2015


    2015-09-30
    Cognitive Impairment - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H2 2015’, provides an overview of the Cognitive Impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7070IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7070IDB
  • View Report: Research and Experts Market Report: Pulmonary Embolism - Pipeline Review, H2 2015

    Pulmonary Embolism - Pipeline Review, H2 2015


    2015-09-30
    Pulmonary Embolism - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Pulmonary Embolism - Pipeline Review, H2 2015’, provides an overview of the Pulmonary Embolism’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7185IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7185IDB
  • View Report: Research and Experts Market Report: Myelofibrosis - Pipeline Review, H2 2015

    Myelofibrosis - Pipeline Review, H2 2015


    2015-09-30
    Myelofibrosis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Myelofibrosis - Pipeline Review, H2 2015’, provides an overview of the Myelofibrosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6980IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC6980IDB
  • View Report: Research and Experts Market Report: Alopecia - Pipeline Review, H2 2015

    Alopecia - Pipeline Review, H2 2015


    2015-09-30
    Alopecia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Alopecia - Pipeline Review, H2 2015’, provides an overview of the Alopecia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6975IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6975IDB
  • View Report: Research and Experts Market Report: Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2015

    Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2015


    2015-09-30
    Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2015’, provides an overview of the Systemic Sclerosis (Scleroderma)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6973IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6973IDB
  • View Report: Research and Experts Market Report: Anthrax - Pipeline Review, H2 2015

    Anthrax - Pipeline Review, H2 2015


    2015-09-30
    Anthrax - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Anthrax - Pipeline Review, H2 2015’, provides an overview of the Anthrax’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6963IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6963IDB
  • View Report: Research and Experts Market Report: Uveitis - Pipeline Review, H2 2015

    Uveitis - Pipeline Review, H2 2015


    2015-09-23
    Uveitis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Uveitis - Pipeline Review, H2 2015’, provides an overview of the Uveitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7087IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7087IDB
  • View Report: Research and Experts Market Report: Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015

    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015


    2015-09-23
    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015’, provides an overview of the Recurrent Glioblastoma Multiforme (GBM)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7083IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7083IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015


    2015-09-23
    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015’, provides an overview of the Relapsed Acute Myeloid Leukemia’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7077IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7077IDB
  • View Report: Research and Experts Market Report: Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2015

    Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2015


    2015-09-23
    Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2015’, provides an overview of the Graft Versus Host Disease (GVHD)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7076IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7076IDB
  • View Report: Research and Experts Market Report: Arterial Thrombosis - Pipeline Review, H2 2015

    Arterial Thrombosis - Pipeline Review, H2 2015


    2015-09-16
    Arterial Thrombosis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Arterial Thrombosis - Pipeline Review, H2 2015’, provides an overview of the Arterial Thrombosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7120IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC7120IDB
  • View Report: Research and Experts Market Report: Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2015

    Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2015


    2015-09-16
    Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2015’, provides an overview of the Gastroesophageal (GE) Junction Carcinomas’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7111IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7111IDB
  • View Report: Research and Experts Market Report: T-Cell Leukemia - Pipeline Review, H2 2015

    T-Cell Leukemia - Pipeline Review, H2 2015


    2015-09-16
    T-Cell Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘T-Cell Leukemia - Pipeline Review, H2 2015’, provides an overview of the T-Cell Leukemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7107IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7107IDB
  • View Report: Research and Experts Market Report: Polycythemia Vera - Pipeline Review, H2 2015

    Polycythemia Vera - Pipeline Review, H2 2015


    2015-09-09
    Polycythemia Vera - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Polycythemia Vera - Pipeline Review, H2 2015’, provides an overview of the Polycythemia Vera’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7144IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7144IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H2 2015

    Systemic Lupus Erythematosus - Pipeline Review, H2 2015


    2015-08-31
    Systemic Lupus Erythematosus - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H2 2015’, provides an overview of the Systemic Lupus Erythematosus’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7059IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7059IDB
  • View Report: Research and Experts Market Report: Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015

    Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015


    2015-08-31
    Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015’, provides an overview of the Squamous Non-Small Cell Lung Cancer’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6982IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6982IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H2 2015

    Gastric Cancer - Pipeline Review, H2 2015


    2015-08-26
    Gastric Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H2 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7055IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7055IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015


    2015-08-19
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7054IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7054IDB
  • View Report: Research and Experts Market Report: Hodgkin Lymphoma - Pipeline Review, H2 2015

    Hodgkin Lymphoma - Pipeline Review, H2 2015


    2015-08-19
    Hodgkin Lymphoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Hodgkin Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Hodgkin Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7052IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7052IDB
  • View Report: Research and Experts Market Report: Brain Metastasis - Pipeline Review, H2 2015

    Brain Metastasis - Pipeline Review, H2 2015


    2015-07-29
    Brain Metastasis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Brain metastasis - Pipeline Review, H2 2015’, provides an overview of the Brain metastasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6938IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6938IDB
  • View Report: Research and Experts Market Report: Progressive Supranuclear Palsy - Pipeline Review, H2 2015

    Progressive Supranuclear Palsy - Pipeline Review, H2 2015


    2015-07-15
    Progressive Supranuclear Palsy - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Progressive Supranuclear Palsy - Pipeline Review, H2 2015’, provides an overview of the Progressive Supranuclear Palsy’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6816IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6816IDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H1 2015

    Metastatic Breast Cancer - Pipeline Review, H1 2015


    2015-06-30
    Metastatic Breast Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Breast Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6507IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6507IDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015


    2015-06-30
    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015’, provides an overview of the Glioblastoma Multiforme (GBM)’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6676IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6676IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H1 2015

    Ovarian Cancer - Pipeline Review, H1 2015


    2015-06-30
    Ovarian Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6675IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6675IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H1 2015

    Pancreatic Cancer - Pipeline Review, H1 2015


    2015-06-30
    Pancreatic Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2015’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6674IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6674IDB
  • View Report: Research and Experts Market Report: Liver Cancer - Pipeline Review, H1 2015

    Liver Cancer - Pipeline Review, H1 2015


    2015-06-30
    Liver Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H1 2015’, provides an overview of the Liver Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6563IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6563IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler

    Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015


    2015-06-30
    Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015’, provides an overview of the Multiple Myeloma (Kahler's Disease)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6505IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6505IDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H1 2015

    Colorectal Cancer - Pipeline Review, H1 2015


    2015-06-30
    Colorectal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2015’, provides an overview of the Colorectal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6504IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6504IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H1 2015

    Melanoma - Pipeline Review, H1 2015


    2015-06-30
    Melanoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Melanoma - Pipeline Review, H1 2015’, provides an overview of the Melanoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6503IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6503IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H1 2015

    Prostate Cancer - Pipeline Review, H1 2015


    2015-06-30
    Prostate Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2015’, provides an overview of the Prostate Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6502IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6502IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Non-Hodgkin Lymphoma - Pipeline Review, H1 2015


    2015-06-30
    Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Non-Hodgkin Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6498IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6498IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Non-Small Cell Lung Cancer - Pipeline Review, H1 2015


    2015-06-30
    Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Non-Small Cell Lung Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6495IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6495IDB
  • View Report: Research and Experts Market Report: Metastatic Colorectal Cancer - Pipeline Review, H1 2015

    Metastatic Colorectal Cancer - Pipeline Review, H1 2015


    2015-06-30
    Metastatic Colorectal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Colorectal Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Colorectal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6570IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6570IDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015


    2015-06-30
    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview of the Chronic Lymphocytic Leukemia (CLL)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6567IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6567IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H1 2015

    Rheumatoid Arthritis - Pipeline Review, H1 2015


    2015-06-30
    Rheumatoid Arthritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2015’, provides an overview of the Rheumatoid Arthritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6561IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6561IDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015


    2015-06-30
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015’, provides an overview...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6509IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6509IDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma - Pipeline Review, H1 2015

    Hepatocellular Carcinoma - Pipeline Review, H1 2015


    2015-06-30
    Hepatocellular Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hepatocellular Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Hepatocellular Carcinoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6499IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6499IDB
  • View Report: Research and Experts Market Report: HIV / AIDS - Pipeline Review, H1 2015

    HIV / AIDS - Pipeline Review, H1 2015


    2015-06-30
    HIV / AIDS - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘HIV / AIDS - Pipeline Review, H1 2015’, provides an overview of the HIV / AIDS’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6496IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6496IDB
  • View Report: Research and Experts Market Report: Inflammatory Bowel Disease - Pipeline Review, H1 2015

    Inflammatory Bowel Disease - Pipeline Review, H1 2015


    2015-06-30
    Inflammatory Bowel Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Inflammatory Bowel Disease - Pipeline Review, H1 2015’, provides an overview of the Inflammatory Bowel Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6494IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6494IDB
  • View Report: Research and Experts Market Report: Crohn

    Crohn's Disease - Pipeline Review, H1 2015


    2015-06-30
    Crohn's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Crohn's Disease - Pipeline Review, H1 2015’, provides an overview of the Crohn's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6569IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6569IDB
  • View Report: Research and Experts Market Report: Thrombosis - Pipeline Review, H1 2015

    Thrombosis - Pipeline Review, H1 2015


    2015-06-30
    Thrombosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Thrombosis - Pipeline Review, H1 2015’, provides an overview of the Thrombosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6511IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6511IDB
  • View Report: Research and Experts Market Report: Kidney Cancer - Pipeline Review, H1 2015

    Kidney Cancer - Pipeline Review, H1 2015


    2015-06-30
    Kidney Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Kidney Cancer - Pipeline Review, H1 2015’, provides an overview of the Kidney Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6492IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6492IDB
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H1 2015

    Neuropathic Pain - Pipeline Review, H1 2015


    2015-06-30
    Neuropathic Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Neuropathic Pain - Pipeline Review, H1 2015’, provides an overview of the Neuropathic Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6491IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6491IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015


    2015-06-30
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6490IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6490IDB
  • View Report: Research and Experts Market Report: Atopic Dermatitis - Pipeline Review, H1 2015

    Atopic Dermatitis - Pipeline Review, H1 2015


    2015-06-30
    Atopic Dermatitis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Atopic Dermatitis - Pipeline Review, H1 2015’, provides an overview of the Atopic Dermatitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6513IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6513IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015


    2015-06-30
    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Head And Neck Cancer Squamous...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6515IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6515IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015


    2015-06-30
    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015’, provides an overview of the Refractory Acute Myeloid Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6519IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6519IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015


    2015-06-30
    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6518IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6518IDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015


    2015-06-30
    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6516IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6516IDB
  • View Report: Research and Experts Market Report: Thrombocytopenia - Pipeline Review, H1 2015

    Thrombocytopenia - Pipeline Review, H1 2015


    2015-06-24
    Thrombocytopenia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Thrombocytopenia - Pipeline Review, H1 2015’, provides an overview of the Thrombocytopenia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6698IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6698IDB
  • View Report: Research and Experts Market Report: Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015


    2015-06-24
    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview of the Refractory Chronic Lymphocytic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6697IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6697IDB
  • View Report: Research and Experts Market Report: Hypercholesterolemia - Pipeline Review, H1 2015

    Hypercholesterolemia - Pipeline Review, H1 2015


    2015-06-24
    Hypercholesterolemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hypercholesterolemia - Pipeline Review, H1 2015’, provides an overview of the Hypercholesterolemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6694IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6694IDB
  • View Report: Research and Experts Market Report: Migraine - Pipeline Review, H1 2015

    Migraine - Pipeline Review, H1 2015


    2015-06-24
    Migraine - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Migraine - Pipeline Review, H1 2015’, provides an overview of the Migraine’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6692IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6692IDB
  • View Report: Research and Experts Market Report: Follicular Lymphoma - Pipeline Review, H1 2015

    Follicular Lymphoma - Pipeline Review, H1 2015


    2015-06-24
    Follicular Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Follicular Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Follicular Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6690IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6690IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H1 2015

    Systemic Lupus Erythematosus - Pipeline Review, H1 2015


    2015-06-24
    Systemic Lupus Erythematosus - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H1 2015’, provides an overview of the Systemic Lupus Erythematosus’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6687IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6687IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer - Pipeline Review, H1 2015

    Small-Cell Lung Cancer - Pipeline Review, H1 2015


    2015-06-24
    Small-Cell Lung Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Small-Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Small-Cell Lung Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6686IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6686IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H1 2015

    Myelodysplastic Syndrome - Pipeline Review, H1 2015


    2015-06-24
    Myelodysplastic Syndrome - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2015’, provides an overview of the Myelodysplastic Syndrome’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6685IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6685IDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015

    Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015


    2015-06-24
    Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Diffuse Large B-Cell Lymphoma’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6684IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6684IDB
  • View Report: Research and Experts Market Report: Renal Cell Carcinoma - Pipeline Review, H1 2015

    Renal Cell Carcinoma - Pipeline Review, H1 2015


    2015-06-24
    Renal Cell Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Renal Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Renal Cell Carcinoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6681IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6681IDB
  • View Report: Research and Experts Market Report: Systemic Mastocytosis - Pipeline Review, H1 2015

    Systemic Mastocytosis - Pipeline Review, H1 2015


    2015-06-17
    Systemic Mastocytosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Systemic Mastocytosis - Pipeline Review, H1 2015’, provides an overview of the Systemic Mastocytosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6807IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6807IDB
  • View Report: Research and Experts Market Report: Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015


    2015-06-17
    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview of the Relapsed Chronic Lymphocytic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6699IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6699IDB
  • View Report: Research and Experts Market Report: Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2015

    Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2015


    2015-06-10
    Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2015’, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6705IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6705IDB
  • View Report: Research and Experts Market Report: Sickle Cell Disease - Pipeline Review, H1 2015

    Sickle Cell Disease - Pipeline Review, H1 2015


    2015-05-29
    Sickle Cell Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Sickle Cell Disease - Pipeline Review, H1 2015’, provides an overview of the Sickle Cell Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6583IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6583IDB
  • View Report: Research and Experts Market Report: Malignant Mesothelioma - Pipeline Review, H1 2015

    Malignant Mesothelioma - Pipeline Review, H1 2015


    2015-05-29
    Malignant Mesothelioma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Malignant Mesothelioma - Pipeline Review, H1 2015’, provides an overview of the Malignant Mesothelioma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6582IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6582IDB
  • View Report: Research and Experts Market Report: Fibrosis - Pipeline Review, H1 2015

    Fibrosis - Pipeline Review, H1 2015


    2015-05-29
    Fibrosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Fibrosis - Pipeline Review, H1 2015’, provides an overview of the Fibrosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6581IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6581IDB
  • View Report: Research and Experts Market Report: Major Depressive Disorder - Pipeline Review, H1 2015

    Major Depressive Disorder - Pipeline Review, H1 2015


    2015-05-29
    Major Depressive Disorder - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Major Depressive Disorder - Pipeline Review, H1 2015’, provides an overview of the Major Depressive Disorder’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6523IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6523IDB
  • View Report: Research and Experts Market Report: Brain Metastasis - Pipeline Review, H1 2015

    Brain Metastasis - Pipeline Review, H1 2015


    2015-05-29
    Brain Metastasis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Brain Metastasis - Pipeline Review, H1 2015’, provides an overview of the Brain Metastasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6593IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6593IDB
  • View Report: Research and Experts Market Report: Psoriatic Arthritis - Pipeline Review, H1 2015

    Psoriatic Arthritis - Pipeline Review, H1 2015


    2015-05-29
    Psoriatic Arthritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Psoriatic Arthritis - Pipeline Review, H1 2015’, provides an overview of the Psoriatic Arthritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6589IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6589IDB
  • View Report: Research and Experts Market Report: Malignant Pleural Mesothelioma - Pipeline Review, H1 2015

    Malignant Pleural Mesothelioma - Pipeline Review, H1 2015


    2015-05-29
    Malignant Pleural Mesothelioma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Malignant Pleural Mesothelioma - Pipeline Review, H1 2015’, provides an overview of the Malignant Pleural Mesothelioma’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6536IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6536IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2015

    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2015


    2015-05-29
    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2015’, provides an overview of the Adenocarcinoma Of The...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6533IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6533IDB
  • View Report: Research and Experts Market Report: Sjogren

    Sjogren's Syndrome - Pipeline Review, H1 2015


    2015-05-20
    Sjogren's Syndrome - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Sjogren's Syndrome - Pipeline Review, H1 2015’, provides an overview of the Sjogren's Syndrome’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6744IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6744IDB
  • View Report: Research and Experts Market Report: Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2015

    Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2015


    2015-05-20
    Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2015’, provides an overview of the Deep Vein Thrombosis (DVT)’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6742IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6742IDB
  • View Report: Research and Experts Market Report: Chronic Urticaria Or Hives - Pipeline Review, H1 2015

    Chronic Urticaria Or Hives - Pipeline Review, H1 2015


    2015-05-20
    Chronic Urticaria Or Hives - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Urticaria Or Hives - Pipeline Review, H1 2015’, provides an overview of the Chronic Urticaria Or Hives’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6739IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6739IDB
  • View Report: Research and Experts Market Report: Vitiligo - Pipeline Review, H1 2015

    Vitiligo - Pipeline Review, H1 2015


    2015-05-13
    Vitiligo - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Vitiligo - Pipeline Review, H1 2015’, provides an overview of the Vitiligo’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6753IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6753IDB
  • View Report: Research and Experts Market Report: Progressive Supranuclear Palsy - Pipeline Review, H1 2015

    Progressive Supranuclear Palsy - Pipeline Review, H1 2015


    2015-05-13
    Progressive Supranuclear Palsy - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Progressive Supranuclear Palsy - Pipeline Review, H1 2015’, provides an overview of the Progressive Supranuclear Palsy’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6758IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6758IDB
  • View Report: Research and Experts Market Report: Lupus Nephritis - Pipeline Review, H1 2015

    Lupus Nephritis - Pipeline Review, H1 2015


    2015-04-30
    Lupus Nephritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Lupus Nephritis - Pipeline Review, H1 2015’, provides an overview of the Lupus Nephritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6550IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6550IDB
  • View Report: Research and Experts Market Report: Tauopathies - Pipeline Review, H1 2015

    Tauopathies - Pipeline Review, H1 2015


    2015-04-29
    Tauopathies - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Tauopathies - Pipeline Review, H1 2015’, provides an overview of the Tauopathies’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6620IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6620IDB
  • View Report: Research and Experts Market Report: Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2015

    Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2015


    2015-04-29
    Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2015’, provides an overview of the Basal Cell Carcinoma (Basal...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6613IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6613IDB
  • View Report: Research and Experts Market Report: Venous (Vein) Thrombosis - Pipeline Review, H1 2015

    Venous (Vein) Thrombosis - Pipeline Review, H1 2015


    2015-04-29
    Venous (Vein) Thrombosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Venous (Vein) Thrombosis - Pipeline Review, H1 2015’, provides an overview of the Venous (Vein) Thrombosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6609IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6609IDB
  • View Report: Research and Experts Market Report: Relapsed Multiple Myeloma - Pipeline Review, H1 2015

    Relapsed Multiple Myeloma - Pipeline Review, H1 2015


    2015-03-31
    Relapsed Multiple Myeloma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Multiple Myeloma - Pipeline Review, H1 2015’, provides an overview of the Relapsed Multiple Myeloma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6247IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6247IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment - Pipeline Review, H1 2015

    Cognitive Impairment - Pipeline Review, H1 2015


    2015-03-31
    Cognitive Impairment - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H1 2015’, provides an overview of the Cognitive Impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6243IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6243IDB
  • View Report: Research and Experts Market Report: HIV-1 Infection - Pipeline Review, H1 2015

    HIV-1 Infection - Pipeline Review, H1 2015


    2015-03-31
    HIV-1 Infection - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘HIV-1 Infection - Pipeline Review, H1 2015’, provides an overview of the HIV-1 Infection’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6239IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6239IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H1 2015

    Gastric Cancer - Pipeline Review, H1 2015


    2015-03-31
    Gastric Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H1 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6238IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6238IDB
  • View Report: Research and Experts Market Report: Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015

    Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015


    2015-03-26
    Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015’, provides an overview of the Idiopathic Pulmonary Fibrosis’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6473IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6473IDB
  • View Report: Research and Experts Market Report: Pulmonary Embolism - Pipeline Review, H1 2015

    Pulmonary Embolism - Pipeline Review, H1 2015


    2015-03-19
    Pulmonary Embolism - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Pulmonary Embolism - Pipeline Review, H1 2015’, provides an overview of the Pulmonary Embolism’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6447IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6447IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015


    2015-03-19
    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015’, provides an overview of the Relapsed Acute Myeloid Leukemia’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6250IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6250IDB
  • View Report: Research and Experts Market Report: Dermatitis - Pipeline Review, H1 2015

    Dermatitis - Pipeline Review, H1 2015


    2015-03-19
    Dermatitis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Dermatitis - Pipeline Review, H1 2015’, provides an overview of the Dermatitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6240IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6240IDB
  • View Report: Research and Experts Market Report: Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2015

    Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2015


    2015-02-28
    Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2015’, provides...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6354IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6354IDB
  • View Report: Research and Experts Market Report: T-Cell Leukemia - Pipeline Review, H1 2015

    T-Cell Leukemia - Pipeline Review, H1 2015


    2015-02-24
    T-Cell Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘T-Cell Leukemia - Pipeline Review, H1 2015’, provides an overview of the T-Cell Leukemia’s therapeutic pipeline.

  • Market Report